STOCK TITAN

Pension gain lifts Graham Holdings (NYSE: GHC) Q2 2026 profit surge

(Moderate)
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

Graham Holdings Company reported sharply higher profitability for the quarter ended June 30, 2026. Operating revenues were $1.30 billion, up from $1.22 billion, and income from operations rose to $83.6 million from $72.8 million. Net income attributable to common stockholders jumped to $281.1 million, with diluted EPS of $64.86 versus $8.35 a year earlier.

Non‑operating items were pivotal: non‑operating pension and postretirement income was $169.6 million, including a $137.0 million pension settlement gain, and gains on marketable equity securities were $101.9 million. Offsetting factors included $19.0 million of Kaplan Languages Group (KLG)‑related impairments, a $5.2 million loss on that sale and a $19.2 million Pillar Two top‑up tax accrual. For the first six months, operating cash flow was $120.4 million; the company returned cash through share repurchases and dividends and ended June with $156.8 million in cash and $900.4 million of total debt on $8.14 billion of assets.

Positive

  • Net income attributable to common stockholders reached $281.1M in Q2 2026, with diluted EPS of $64.86 versus $8.35 a year earlier, as higher operating income was amplified by large pension and marketable equity security gains.
  • Net interest expense for the first six months was $29.0M, down from $95.6M in the prior-year period, reflecting the 2025 refinancing, new 5.625% notes and the settlement of mandatorily redeemable noncontrolling interests.

Negative

  • Impairments and tax charges reduced 2026 earnings, including $19.0M of KLG-related impairments, a $5.2M loss on the Kaplan Languages Group sale, a $5.8M impairment on an affiliate and a $19.2M Pillar Two top-up tax accrual.

Filing Explained

The June pension annuity transferred responsibility for $124.3 million of retiree obligations to an insurer without changing promised benefits.

As a Form 10-Q, this filing provides unaudited interim financial updates; it also records that the Kaplan Languages Group sale closed on May 1, 2026, so that business is no longer held by the company and the sale generated a $5.2 million loss.

In June 2026, the company used $113.9 million of pension-plan assets to buy an irrevocable group annuity covering $124.3 million of obligations. The insurer must now pay and administer benefits for about 1,080 retirees and beneficiaries, while the company reports no change in the amount, timing, or form of payments.

The company also bought additional minority-owned CSI Pharmacy shares and now owns 93.4% of CSI; the $41.0 million transaction included $16.4 million of cash and $24.6 million of promissory notes due in quarterly installments through April 1, 2028.

The KLG transaction produced a $69.6 million U.S. tax benefit but also a $19.2 million Pillar Two accrual. The accrual could be completely reversed without payment if the U.K. and other relevant countries adopt the cited safe-harbor guidance, making local implementation the specific unresolved item.

Operating Revenues $1.30B Three months ended June 30, 2026
Net Income to Common $281.1M Q2 2026 net income attributable to Graham Holdings Company common stockholders
Diluted EPS $64.86 Diluted earnings per share for the quarter ended June 30, 2026
Net Cash from Operating Activities $120.4M Net cash provided by operating activities, six months ended June 30, 2026
Total Debt $900.4M Total borrowings outstanding as of June 30, 2026
Cash and Cash Equivalents $156.8M Cash and cash equivalents balance at June 30, 2026
Pension Settlement Gain $137.0M One-time pre-tax settlement gain from purchase of a group annuity in June 2026
Pillar Two Top-up Tax Accrual $19.2M Pillar Two top-up income tax accrual and expense recorded for 2026
mandatorily redeemable noncontrolling interest financial
"The mandatorily redeemable noncontrolling interest related to GHC One is reported as a current liability"
A mandatorily redeemable noncontrolling interest is a minority ownership stake that the issuing company is legally required to buy back or repay at a set future date or upon a specific trigger. Think of it as a hybrid between an ownership share and a timed loan — it gives outsiders a stake today but creates a known cash obligation later. Investors watch it because it can change reported leverage, reduce future cash available for operations or dividends, and affect how risky the company appears.
Pillar Two top-up income tax financial
"recorded a Pillar Two top-up income tax accrual and expense of $19.2 million"
Side-by-Side (SbS) Safe Harbor regulatory
"administrative guidance introducing a Side-by-Side (SbS) Safe Harbor that would effectively exempt U.S. parent groups"
EBITDAP financial
"Earnings Before Interest, Income Taxes, Depreciation, Amortization and Pension Service Cost (EBITDAP)"
vehicle floor plan payable financial
"Accounts payable, vehicle floor plan payable and accrued liabilities consist of the following"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How did Graham Holdings (GHC) perform financially in Q2 2026?

Graham Holdings generated $1.30B of operating revenues in Q2 2026, up from $1.22B a year earlier. Income from operations was $83.6M, while net income attributable to common stockholders rose to $281.1M and diluted EPS reached $64.86.

What drove the rise in Graham Holdings (GHC) net income in 2026?

Net income increased mainly due to $169.6M of non-operating pension and postretirement income, including a $137.0M settlement gain, and $101.9M of gains on marketable equity securities. These more than offset KLG-related impairments, a $5.2M loss on that sale and the $19.2M Pillar Two tax accrual.

What were Graham Holdings (GHC) cash flows and leverage in the first half of 2026?

For the six months ended June 30, 2026, Graham Holdings generated $120.4M of net cash from operating activities. The company used cash for investing and financing activities, returned capital via share repurchases and dividends, and finished with $156.8M in cash and $900.4M of total debt.

How did the Kaplan Languages Group sale impact Graham Holdings (GHC)?

Kaplan’s sale of KLG led to $19.0M of impairment charges in 2026, consisting of $1.0M of goodwill impairment and $18.0M on the asset group, plus a $5.2M non-operating loss on the sale. Related restructuring generated a $69.6M U.S. income tax benefit.

What is the Pillar Two tax impact on Graham Holdings (GHC) in 2026?

The company recorded a $19.2M Pillar Two top-up income tax accrual and expense tied to the large U.S. tax benefit from the KLG transaction. Management notes that wider adoption of the Side-by-Side Safe Harbor in non-U.S. jurisdictions could allow reversal of this accrual.

How concentrated are Graham Holdings (GHC) pension plan assets?

Defined benefit pension assets are diversified but include concentrations. At June 30, 2026, one common stock and one private investment fund together represented about 37% of total plan assets, and holdings included $113.3M of Markel shares alongside significant Berkshire Hathaway exposure.
false2026Q2000010488912/31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesghc:televisionStationghc:automotiveDealershipghc:schoolsghc:countryghc:businessxbrli:pureiso4217:GBPghc:numberOfRetireesAndBeneficiariesghc:companyghc:investmentghc:claimghc:segment00001048892026-01-012026-06-300000104889us-gaap:CommonClassAMember2026-07-240000104889us-gaap:CommonClassBMember2026-07-240000104889us-gaap:ServiceMember2026-04-012026-06-300000104889us-gaap:ServiceMember2025-04-012025-06-300000104889us-gaap:ServiceMember2026-01-012026-06-300000104889us-gaap:ServiceMember2025-01-012025-06-300000104889us-gaap:ProductMember2026-04-012026-06-300000104889us-gaap:ProductMember2025-04-012025-06-300000104889us-gaap:ProductMember2026-01-012026-06-300000104889us-gaap:ProductMember2025-01-012025-06-3000001048892026-04-012026-06-3000001048892025-04-012025-06-3000001048892025-01-012025-06-3000001048892026-06-3000001048892025-12-3100001048892024-12-3100001048892025-06-300000104889us-gaap:CommonStockMember2025-12-310000104889us-gaap:AdditionalPaidInCapitalMember2025-12-310000104889us-gaap:RetainedEarningsMember2025-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000104889us-gaap:TreasuryStockCommonMember2025-12-310000104889us-gaap:NoncontrollingInterestMember2025-12-310000104889us-gaap:RetainedEarningsMember2026-01-012026-03-3100001048892026-01-012026-03-310000104889us-gaap:NoncontrollingInterestMember2026-01-012026-03-310000104889us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310000104889us-gaap:TreasuryStockCommonMember2026-01-012026-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310000104889us-gaap:CommonStockMember2026-03-310000104889us-gaap:AdditionalPaidInCapitalMember2026-03-310000104889us-gaap:RetainedEarningsMember2026-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310000104889us-gaap:TreasuryStockCommonMember2026-03-310000104889us-gaap:NoncontrollingInterestMember2026-03-3100001048892026-03-310000104889us-gaap:RetainedEarningsMember2026-04-012026-06-300000104889us-gaap:NoncontrollingInterestMember2026-04-012026-06-300000104889us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300000104889us-gaap:TreasuryStockCommonMember2026-04-012026-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300000104889us-gaap:CommonStockMember2026-06-300000104889us-gaap:AdditionalPaidInCapitalMember2026-06-300000104889us-gaap:RetainedEarningsMember2026-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300000104889us-gaap:TreasuryStockCommonMember2026-06-300000104889us-gaap:NoncontrollingInterestMember2026-06-300000104889us-gaap:CommonStockMember2024-12-310000104889us-gaap:AdditionalPaidInCapitalMember2024-12-310000104889us-gaap:RetainedEarningsMember2024-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000104889us-gaap:TreasuryStockCommonMember2024-12-310000104889us-gaap:NoncontrollingInterestMember2024-12-310000104889us-gaap:RetainedEarningsMember2025-01-012025-03-3100001048892025-01-012025-03-310000104889us-gaap:NoncontrollingInterestMember2025-01-012025-03-310000104889us-gaap:TreasuryStockCommonMember2025-01-012025-03-310000104889us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000104889us-gaap:CommonStockMember2025-03-310000104889us-gaap:AdditionalPaidInCapitalMember2025-03-310000104889us-gaap:RetainedEarningsMember2025-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000104889us-gaap:TreasuryStockCommonMember2025-03-310000104889us-gaap:NoncontrollingInterestMember2025-03-3100001048892025-03-310000104889us-gaap:RetainedEarningsMember2025-04-012025-06-300000104889us-gaap:NoncontrollingInterestMember2025-04-012025-06-300000104889us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300000104889us-gaap:TreasuryStockCommonMember2025-04-012025-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000104889us-gaap:CommonStockMember2025-06-300000104889us-gaap:AdditionalPaidInCapitalMember2025-06-300000104889us-gaap:RetainedEarningsMember2025-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000104889us-gaap:TreasuryStockCommonMember2025-06-300000104889us-gaap:NoncontrollingInterestMember2025-06-300000104889ghc:TelevisionBroadcastingMember2026-06-300000104889ghc:AutomotiveMember2026-06-300000104889ghc:KaplanLanguagesGroupKLGMember2026-02-010000104889ghc:OtherHealthcareMemberghc:HealthcareDivisionMember2026-03-012026-03-3100001048892025-01-012025-12-310000104889ghc:EducationMember2025-01-012025-12-310000104889ghc:OtherHealthcareMemberghc:HealthcareDivisionMember2025-01-012025-12-310000104889ghc:ManufacturingMember2025-01-012025-12-310000104889ghc:AutomotiveMember2025-01-012025-12-310000104889ghc:SupplementalEducationMemberghc:EducationMember2025-06-012025-06-300000104889ghc:ManufacturingMemberghc:ArconicArchitecturalProductsLLCMemberghc:HooverTreatedWoodProductsMember2025-07-310000104889ghc:OtherHealthcareMemberghc:HealthcareDivisionMember2025-10-012025-10-310000104889ghc:AutomotiveMemberghc:HondaAutoDealershipMember2025-10-310000104889us-gaap:DelayedDrawTermLoanMemberghc:AutomotiveMemberghc:HondaAutoDealershipMember2025-10-310000104889us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2025-12-310000104889ghc:KaplanLanguagesGroupKLGMember2026-04-012026-06-300000104889ghc:KaplanLanguagesGroupKLGMember2026-01-012026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2026-03-012026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:CashPaidForCSIMinoritySharesMember2026-03-012026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNotesForCSIMinoritySharesDue2028Member2026-03-012026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNotesForCSIMinoritySharesDue2028Member2026-03-310000104889ghc:GrahamHoldingsCompanyMemberghc:CSIPharmacyHoldingCompanyLLCMember2026-06-300000104889ghc:ClarusMember2026-01-012026-01-310000104889ghc:GrahamHoldingsCompanyMemberghc:ClarusMember2026-06-300000104889ghc:ClarusMember2025-10-012025-10-310000104889ghc:GrahamHoldingsCompanyMemberghc:ClarusMember2025-10-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2025-07-012025-07-310000104889ghc:GHCOneMember2025-02-250000104889ghc:GHCOneMemberghc:CashPaidToSettleASignificantPortionOfTheMandatorilyRedeemableNoncontrollingInterestMember2025-02-250000104889ghc:GHCOneMemberghc:GHCClassBCommonStockIssuedMember2025-02-250000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMemberghc:GHCOneMember2025-02-252025-02-250000104889ghc:RemainingGHCOneAndGHCTwoMember2026-06-300000104889ghc:GHCOneMember2026-06-300000104889ghc:CSIPharmacyHoldingCompanyLLCMember2024-12-012024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:CashPaidForCSIMinoritySharesMember2024-12-012024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNoteForCSIMinoritySharesDue2026Member2024-12-012024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNoteForCSIMinoritySharesDue2026Member2024-12-310000104889ghc:GrahamHoldingsCompanyMemberghc:CSIPharmacyHoldingCompanyLLCMember2024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:AdditionalAmountPayableForCSIMinoritySharesMember2025-12-012025-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:AdditionalAmountPayableForCSIMinoritySharesMember2025-12-310000104889ghc:MarkelGroupIncMember2026-06-300000104889ghc:MarkelGroupIncMember2025-12-310000104889us-gaap:CommonClassAMemberghc:BerkshireHathawayMember2026-06-300000104889us-gaap:CommonClassBMemberghc:BerkshireHathawayMember2026-06-300000104889ghc:BerkshireHathawayMember2026-06-300000104889ghc:ConcentrationInSingleMarketableEquitySecurityMemberus-gaap:AssetsTotalMember2026-01-012026-06-300000104889ghc:HealthcareDivisionMemberghc:MaryFreeBedAtHomeMember2026-06-300000104889ghc:HealthcareDivisionMemberghc:ResidentialHomeHealthIllinoisMember2026-06-300000104889ghc:HealthcareDivisionMemberghc:AlleghenyHealthNetworkHealthcareAtHomeMember2026-06-300000104889ghc:HealthcareDivisionMemberghc:ResidentialHospiceIllinoisMember2026-06-300000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2026-04-012026-06-300000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2026-01-012026-06-300000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2025-04-012025-06-300000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2025-01-012025-06-300000104889ghc:N2KNetworksMember2026-06-300000104889ghc:RealmMember2026-06-300000104889ghc:IntersectionMember2026-06-300000104889ghc:N2KNetworksMember2024-05-012024-05-310000104889ghc:RealmMember2026-04-012026-06-300000104889ghc:KIHLMemberghc:YorkJointVentureMember2026-06-300000104889ghc:KIHLMemberghc:YorkJointVentureMember2026-01-012026-06-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2026-04-012026-06-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2026-01-012026-06-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2025-04-012025-06-300000104889ghc:VehicleFloorPlanFacilityMemberghc:AutomotiveMember2025-01-012025-06-300000104889ghc:AutomotiveMember2026-04-012026-06-300000104889ghc:AutomotiveMember2025-04-012025-06-300000104889ghc:AutomotiveMember2026-01-012026-06-300000104889ghc:AutomotiveMember2025-01-012025-06-300000104889ghc:VehicleFloorPlanFacilityNewVehiclesMemberghc:AutomotiveMember2026-06-300000104889ghc:VehicleFloorPlanFacilityNewVehiclesMemberghc:AutomotiveMember2025-12-310000104889ghc:KaplanInternationalMemberghc:EducationMember2026-01-012026-03-310000104889ghc:EducationMember2025-12-310000104889ghc:TelevisionBroadcastingMember2025-12-310000104889ghc:HealthcareDivisionMember2025-12-310000104889ghc:ManufacturingMember2025-12-310000104889ghc:AutomotiveMember2025-12-310000104889us-gaap:AllOtherSegmentsMember2025-12-310000104889ghc:EducationMember2026-01-012026-06-300000104889ghc:TelevisionBroadcastingMember2026-01-012026-06-300000104889ghc:HealthcareDivisionMember2026-01-012026-06-300000104889ghc:ManufacturingMember2026-01-012026-06-300000104889us-gaap:AllOtherSegmentsMember2026-01-012026-06-300000104889ghc:EducationMember2026-06-300000104889ghc:HealthcareDivisionMember2026-06-300000104889ghc:ManufacturingMember2026-06-300000104889us-gaap:AllOtherSegmentsMember2026-06-300000104889ghc:EducationAndHealthcareDivisionsMember2026-01-012026-06-300000104889ghc:KaplanInternationalMemberghc:EducationMember2025-12-310000104889ghc:HigherEducationMemberghc:EducationMember2025-12-310000104889ghc:SupplementalEducationMemberghc:EducationMember2025-12-310000104889ghc:CSIPharmacyMemberghc:HealthcareDivisionMember2025-12-310000104889ghc:OtherHealthcareMemberghc:HealthcareDivisionMember2025-12-310000104889ghc:KaplanInternationalMemberghc:EducationMember2026-01-012026-06-300000104889ghc:HigherEducationMemberghc:EducationMember2026-01-012026-06-300000104889ghc:SupplementalEducationMemberghc:EducationMember2026-01-012026-06-300000104889ghc:CSIPharmacyMemberghc:HealthcareDivisionMember2026-01-012026-06-300000104889ghc:OtherHealthcareMemberghc:HealthcareDivisionMember2026-01-012026-06-300000104889ghc:KaplanInternationalMemberghc:EducationMember2026-06-300000104889ghc:HigherEducationMemberghc:EducationMember2026-06-300000104889ghc:SupplementalEducationMemberghc:EducationMember2026-06-300000104889ghc:CSIPharmacyMemberghc:HealthcareDivisionMember2026-06-300000104889ghc:OtherHealthcareMemberghc:HealthcareDivisionMember2026-06-300000104889srt:MinimumMemberus-gaap:CustomerRelationshipsMember2026-06-300000104889srt:MinimumMemberus-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MaximumMemberus-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MaximumMemberus-gaap:CustomerRelationshipsMember2026-06-300000104889us-gaap:CustomerRelationshipsMember2026-06-300000104889us-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MinimumMemberus-gaap:TrademarksAndTradeNamesMember2025-12-310000104889srt:MinimumMemberus-gaap:TrademarksAndTradeNamesMember2026-06-300000104889srt:MaximumMemberus-gaap:TrademarksAndTradeNamesMember2025-12-310000104889srt:MaximumMemberus-gaap:TrademarksAndTradeNamesMember2026-06-300000104889us-gaap:TrademarksAndTradeNamesMember2026-06-300000104889us-gaap:TrademarksAndTradeNamesMember2025-12-310000104889us-gaap:ContractBasedIntangibleAssetsMember2026-06-300000104889us-gaap:ContractBasedIntangibleAssetsMember2025-12-310000104889srt:MinimumMemberus-gaap:DatabasesMember2026-06-300000104889srt:MinimumMemberus-gaap:DatabasesMember2025-12-310000104889srt:MaximumMemberus-gaap:DatabasesMember2026-06-300000104889srt:MaximumMemberus-gaap:DatabasesMember2025-12-310000104889us-gaap:DatabasesMember2026-06-300000104889us-gaap:DatabasesMember2025-12-310000104889srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2026-06-300000104889srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2025-12-310000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2026-06-300000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2025-12-310000104889us-gaap:OtherIntangibleAssetsMember2026-06-300000104889us-gaap:OtherIntangibleAssetsMember2025-12-310000104889us-gaap:FranchiseRightsMember2026-06-300000104889us-gaap:FranchiseRightsMember2025-12-310000104889us-gaap:TrademarksAndTradeNamesMember2026-06-300000104889us-gaap:TrademarksAndTradeNamesMember2025-12-310000104889us-gaap:OperatingAndBroadcastRightsMember2026-06-300000104889us-gaap:OperatingAndBroadcastRightsMember2025-12-310000104889us-gaap:OtherIntangibleAssetsMember2026-06-300000104889us-gaap:OtherIntangibleAssetsMember2025-12-310000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2026-06-300000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2025-12-310000104889ghc:FiveYearCreditAgreementMaturingIn2030Membersrt:MinimumMember2026-06-300000104889ghc:FiveYearCreditAgreementMaturingIn2030Membersrt:MaximumMember2026-06-300000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2026-06-300000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2025-12-310000104889ghc:RealEstateTermLoanMaturingIn2028Membersrt:MinimumMember2026-06-300000104889ghc:RealEstateTermLoanMaturingIn2028Membersrt:MaximumMember2026-06-300000104889ghc:RealEstateTermLoanMaturingIn2028Member2026-06-300000104889ghc:RealEstateTermLoanMaturingIn2028Member2025-12-310000104889ghc:CapitalTermLoanMaturingIn2028Membersrt:MinimumMember2026-06-300000104889ghc:CapitalTermLoanMaturingIn2028Membersrt:MaximumMember2026-06-300000104889ghc:CapitalTermLoanMaturingIn2028Member2026-06-300000104889ghc:CapitalTermLoanMaturingIn2028Member2025-12-310000104889ghc:OtherIndebtednessMembersrt:MinimumMember2026-06-300000104889ghc:OtherIndebtednessMembersrt:MaximumMember2026-06-300000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2025-11-240000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2025-11-242025-11-240000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2025-11-240000104889ghc:TermLoanMaturingIn2027Member2025-11-242025-11-240000104889us-gaap:DelayedDrawTermLoanMemberghc:AutomotiveMember2025-10-210000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2025-11-240000104889ghc:USDRevolvingCreditFacilityBorrowingsMember2026-06-300000104889ghc:USDRevolvingCreditFacilityBorrowingsMemberus-gaap:SecuredOvernightFinancingRateSofrMember2026-01-012026-06-300000104889ghc:USDRevolvingCreditFacilityBorrowingsMemberus-gaap:PrimeRateMember2026-01-012026-06-300000104889ghc:GBPRevolvingCreditFacilityBorrowingsMember2026-06-300000104889ghc:GBPRevolvingCreditFacilityBorrowingsMemberghc:SterlingOvernightInterbankAverageRateSONIAMember2026-01-012026-06-300000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2026-04-012026-06-300000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2026-01-012026-06-300000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2025-04-012025-06-300000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2025-01-012025-06-300000104889us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-300000104889us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-300000104889us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-06-300000104889us-gaap:FairValueMeasurementsRecurringMember2026-06-300000104889us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310000104889us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310000104889us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310000104889us-gaap:FairValueMeasurementsRecurringMember2025-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:ContingentConsiderationLiabilitiesMember2025-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2025-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:ContingentConsiderationLiabilitiesMember2026-01-012026-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2026-01-012026-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:ContingentConsiderationLiabilitiesMember2026-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2026-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:ContingentConsiderationLiabilitiesMember2024-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2024-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:ContingentConsiderationLiabilitiesMember2025-01-012025-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2025-01-012025-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:ContingentConsiderationLiabilitiesMember2025-06-300000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2025-06-300000104889ghc:GHCOneAndGHCTwoMemberghc:GrahamHoldingsCompanyMember2026-01-012026-06-300000104889ghc:GHCOneAndGHCTwoMemberghc:GroupofSeniorManagersofGHGMember2026-01-012026-06-300000104889ghc:GrahamHoldingsCompanyMemberghc:GHCOneAndGHCTwoMember2026-01-012026-06-300000104889ghc:GroupofSeniorManagersofGHGMemberghc:GHCOneAndGHCTwoMemberghc:GHCOneAndGHCTwoMember2026-06-300000104889ghc:GroupofSeniorManagersofGHGMemberghc:GHCOneAndGHCTwoMember2026-01-012026-06-300000104889ghc:KaplanLanguagesGroupKLGMember2026-01-012026-06-300000104889us-gaap:DomesticTaxJurisdictionFederalStateAndLocalMemberghc:KaplanLanguagesGroupKLGMember2026-01-012026-06-300000104889us-gaap:ForeignCountryMemberghc:KaplanLanguagesGroupKLGMember2026-01-012026-06-300000104889ghc:KaplanLanguagesGroupKLGMemberghc:OrganisationForEconomicCoOperationAndDevelopmentOECDPillarTwoMember2026-06-300000104889ghc:KaplanLanguagesGroupKLGMemberghc:OrganisationForEconomicCoOperationAndDevelopmentOECDPillarTwoMember2026-01-012026-06-300000104889country:US2026-04-012026-06-300000104889country:US2026-01-012026-06-300000104889us-gaap:NonUsMember2026-04-012026-06-300000104889us-gaap:NonUsMember2026-01-012026-06-300000104889country:US2025-04-012025-06-300000104889country:US2025-01-012025-06-300000104889us-gaap:NonUsMember2025-04-012025-06-300000104889us-gaap:NonUsMember2025-01-012025-06-300000104889us-gaap:TransferredOverTimeMember2026-04-012026-06-300000104889us-gaap:TransferredOverTimeMember2026-01-012026-06-300000104889us-gaap:TransferredAtPointInTimeMember2026-04-012026-06-300000104889us-gaap:TransferredAtPointInTimeMember2026-01-012026-06-300000104889us-gaap:TransferredOverTimeMember2025-04-012025-06-300000104889us-gaap:TransferredOverTimeMember2025-01-012025-06-300000104889us-gaap:TransferredAtPointInTimeMember2025-04-012025-06-300000104889us-gaap:TransferredAtPointInTimeMember2025-01-012025-06-300000104889ghc:KaplanInternationalMember2026-06-300000104889ghc:KaplanInternationalMember2026-07-01us-gaap:LongTermContractWithCustomerMember2026-06-300000104889ghc:KaplanInternationalMember2025-12-310000104889ghc:AdditionalContractAssetsMember2026-06-300000104889ghc:AdditionalContractAssetsMember2025-12-310000104889ghc:SupplementalEducationMemberus-gaap:LongTermContractWithCustomerMember2026-01-012026-06-300000104889ghc:SupplementalEducationMember2026-07-01us-gaap:LongTermContractWithCustomerMember2026-06-300000104889ghc:SupplementalEducationMemberus-gaap:LongTermContractWithCustomerMember2026-06-300000104889us-gaap:EmployeeStockOptionMember2026-04-012026-06-300000104889us-gaap:EmployeeStockOptionMember2025-04-012025-06-300000104889us-gaap:EmployeeStockOptionMember2026-01-012026-06-300000104889us-gaap:EmployeeStockOptionMember2025-01-012025-06-300000104889us-gaap:RestrictedStockMemberus-gaap:CommonClassBMember2026-04-012026-06-300000104889us-gaap:RestrictedStockMemberus-gaap:CommonClassBMember2025-04-012025-06-300000104889us-gaap:RestrictedStockMemberus-gaap:CommonClassBMember2026-01-012026-06-300000104889us-gaap:RestrictedStockMemberus-gaap:CommonClassBMember2025-01-012025-06-300000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2026-01-012026-06-300000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2025-01-012025-06-300000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2026-04-012026-06-300000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2025-04-012025-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2026-01-012026-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2026-04-012026-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2025-04-012025-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-06-300000104889ghc:IrrevocableGroupAnnuityContractPurchaseMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-012026-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:DekkoMemberghc:VoluntaryRetirementIncentiveProgramMember2026-04-012026-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:KaplanGrahamMediaGroupCode3AndSlateMemberghc:SeparationIncentiveProgramMember2026-04-012026-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:KaplanGrahamMediaGroupJoyceDekkoFramebridgeCode3SlateAndCorporateMemberghc:SeparationIncentiveProgramMember2026-01-012026-03-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:KaplanGrahamMediaGroupWGBSaatchiArtSociety6Code3AndDecileMemberghc:SeparationIncentiveProgramMember2025-04-012025-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:WorldOfGoodBrandsMemberghc:SeparationIncentiveProgramMember2025-01-012025-03-310000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2026-01-012026-06-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2026-04-012026-06-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2025-04-012025-06-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2025-01-012025-06-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889us-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:AlphabetAndBerkshireHathawayCommonStockMemberghc:InvestmentManager1Memberus-gaap:PensionPlansDefinedBenefitMember2026-01-012026-06-300000104889ghc:ForeignInvestmentsMemberghc:InvestmentManager1Membersrt:MaximumMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889ghc:BerkshireHathawayCommonStockMemberghc:InvestmentManager2Memberus-gaap:PensionPlansDefinedBenefitMember2026-01-012026-06-300000104889ghc:ForeignInvestmentsMemberghc:InvestmentManager2Membersrt:MaximumMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2026-01-012026-06-300000104889ghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMemberghc:DefinedBenefitPlanAssetsTotalMemberus-gaap:PensionPlansDefinedBenefitMember2026-01-012026-06-300000104889ghc:SingleEquityConcentrationMemberus-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889ghc:SingleEquityConcentrationMemberus-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889ghc:SingleEquityConcentrationMemberus-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:SingleEquityConcentrationMemberus-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMemberghc:DefinedBenefitPlanAssetsTotalMemberus-gaap:PensionPlansDefinedBenefitMember2025-01-012025-09-300000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:MarkelGroupIncMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-300000104889ghc:MarkelGroupIncMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:KaplanLanguagesGroupKLGMemberghc:EducationMember2026-04-012026-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2026-04-012026-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2025-04-012025-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2026-04-012026-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-04-012025-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2026-04-012026-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2025-04-012025-06-300000104889ghc:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainsIncludedInNetIncomeMember2026-04-012026-06-300000104889ghc:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainsIncludedInNetIncomeMember2025-04-012025-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-04-012026-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-04-012025-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-04-012026-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-04-012025-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2026-01-012026-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-01-012025-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2026-01-012026-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2025-01-012025-06-300000104889ghc:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainsIncludedInNetIncomeMember2026-01-012026-06-300000104889ghc:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainsIncludedInNetIncomeMember2025-01-012025-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-01-012026-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-01-012026-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-12-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-01-012026-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2026-06-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-06-300000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-01-012026-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-01-012026-06-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-01-012026-06-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300000104889srt:MaximumMember2026-06-300000104889ghc:EducationMemberghc:PurdueUniversityGlobalMemberghc:HigherEducationMember2026-06-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:PurdueUniversityGlobalMemberghc:HigherEducationMember2026-06-300000104889ghc:EducationMemberghc:KaplanUniversityTransactionMemberghc:PurdueUniversityGlobalMemberghc:HigherEducationMember2018-03-222018-03-220000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2026-04-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2026-04-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2026-04-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2026-04-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2026-04-012026-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2026-04-012026-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2026-04-012026-06-300000104889us-gaap:IntersegmentEliminationMember2026-04-012026-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2026-04-012026-06-300000104889us-gaap:CorporateNonSegmentMember2026-04-012026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2025-04-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2025-04-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2025-04-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2025-04-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2025-04-012025-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2025-04-012025-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2025-04-012025-06-300000104889us-gaap:IntersegmentEliminationMember2025-04-012025-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2025-04-012025-06-300000104889us-gaap:CorporateNonSegmentMember2025-04-012025-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2026-01-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2026-01-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2026-01-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2026-01-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2026-01-012026-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2026-01-012026-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2026-01-012026-06-300000104889us-gaap:IntersegmentEliminationMember2026-01-012026-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2026-01-012026-06-300000104889us-gaap:CorporateNonSegmentMember2026-01-012026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2025-01-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2025-01-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2025-01-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2025-01-012025-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2025-01-012025-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2025-01-012025-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:CorporateAndOtherMember2025-01-012025-06-300000104889us-gaap:IntersegmentEliminationMember2025-01-012025-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2025-01-012025-06-300000104889us-gaap:CorporateNonSegmentMember2025-01-012025-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2026-06-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2026-06-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2026-06-300000104889us-gaap:OperatingSegmentsMemberghc:EducationMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2026-06-300000104889us-gaap:OperatingSegmentsMemberghc:TelevisionBroadcastingMember2025-12-310000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2026-06-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2026-06-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2026-06-300000104889us-gaap:OperatingSegmentsMemberghc:HealthcareDivisionMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2026-06-300000104889us-gaap:OperatingSegmentsMemberghc:ManufacturingMember2025-12-310000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2026-06-300000104889us-gaap:OperatingSegmentsMemberghc:AutomotiveMember2025-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2026-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember2025-12-310000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2026-06-300000104889us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2025-12-310000104889us-gaap:CorporateNonSegmentMember2026-06-300000104889us-gaap:CorporateNonSegmentMember2025-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended June 30, 2026
or
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number 001-06714
GRAHAM HOLDINGS COMPANY
(Exact name of registrant as specified in its charter)
Delaware53-0182885
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1812 North Moore Street, Arlington, Virginia

22209
(Address of principal executive offices)(Zip Code)
(703) 345-6300
(Registrant’s telephone number, including area code)
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class B Common Stock, par value $1.00 per share GHCNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  .    No  .
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  .    No  .  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated
filer
Non-accelerated
filer
Smaller reporting
company
Emerging growth
company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  .    No  .  
Shares outstanding at July 24, 2026:
Class A Common Stock – 964,001 Shares
Class B Common Stock – 3,270,927 Shares



GRAHAM HOLDINGS COMPANY
Index to Form 10-Q
 
PART I. FINANCIAL INFORMATION
 
Item 1.
Financial Statements
 
 
Condensed Consolidated Statements of Operations
1
 
 
 
 
Condensed Consolidated Statements of Comprehensive Income
2
 
 
 
 
Condensed Consolidated Balance Sheets
3
 
 
 
 
Condensed Consolidated Statements of Cash Flows
4
Condensed Consolidated Statements of Changes in Common Stockholders' Equity
5
 
 
 
 
Notes to Condensed Consolidated Financial Statements
7

Organization, Basis of Presentation and Recent Accounting Pronouncements
7

Acquisitions and Dispositions of Businesses
8

Investments
10

Accounts Receivable, Accounts Payable, Vehicle Floor Plan Payable and Accrued Liabilities
11

Inventories and Contracts in Progress
12

Goodwill and Other Intangible Assets
12

Debt
13

Fair Value Measurements
15

Income Taxes
16

Revenue From Contracts With Customers
17

Earnings Per Share
18

Pension Plans
19

Other Non-Operating Expense
21

Accumulated Other Comprehensive Income (Loss)
21

Contingencies
22

Business Segments
22
Item 2.
Management’s Discussion and Analysis of Results of Operations and Financial Condition
32
 
 
 
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
44
 
 
 
Item 4.
Controls and Procedures
44
 
 
PART II. OTHER INFORMATION
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
46
Item 5.
Other Information
46
Item 6.
Exhibits
47
 
 
Signatures
48



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
  
(in thousands, except per share amounts)2026202520262025
Operating Revenues
Sales of services$664,565 $668,627 $1,338,364 $1,316,134 
Sales of goods637,941 547,145 1,200,134 1,065,553 
1,302,506 1,215,772 2,538,498 2,381,687 
Operating Costs and Expenses    
Cost of services sold (exclusive of items shown below)384,996 389,316 779,989 775,452 
Cost of goods sold (exclusive of items shown below)525,479 450,122 987,686 883,344 
Selling, general and administrative284,138 276,690 561,619 547,396 
Depreciation of property, plant and equipment18,281 19,652 36,675 40,206 
Amortization of intangible assets5,978 7,241 12,033 15,065 
Impairment of goodwill and asset group held for sale  19,029  
  1,218,872 1,143,021 2,397,031 2,261,463 
Income from Operations
83,634 72,751 141,467 120,224 
Equity in (losses) earnings of affiliates, net
(19,863)3,114 14,987 (5,314)
Interest income1,881 2,261 4,356 4,761 
Interest expense(17,173)(18,106)(33,402)(100,383)
Non-operating pension and postretirement benefit income, net169,649 28,602 200,722 63,219 
Gain (loss) on marketable equity securities, net
101,879 (11,543)32,956 32,258 
Other expense, net(2,531)(16,456)(2,959)(20,521)
Income Before Income Taxes
317,476 60,623 358,127 94,244 
Provision for Income Taxes
35,100 20,200 45,000 28,100 
Net Income
282,376 40,423 313,127 66,144 
Net Income Attributable to Noncontrolling Interests(1,273)(3,674)(2,918)(5,501)
Net Income Attributable to Graham Holdings Company Common Stockholders
$281,103 $36,749 $310,209 $60,643 
Per Share Information Attributable to Graham Holdings Company Common Stockholders
      
Basic net income per common share
$65.53 $8.43 $71.76 $13.93 
Basic average number of common shares outstanding4,265 4,333 4,298 4,327 
Diluted net income per common share
$64.86 $8.35 $71.04 $13.81 
Diluted average number of common shares outstanding4,309 4,373 4,342 4,366 
See accompanying Notes to Condensed Consolidated Financial Statements.
1


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2026202520262025
Net Income$282,376 $40,423 $313,127 $66,144 
Other Comprehensive (Loss) Income, Before Tax      
Foreign currency translation adjustments:      
Translation adjustments arising during the period125 32,283 (6,123)46,550 
Adjustment for sales of businesses with foreign operations6,175 646 6,175 646 
6,300 32,929 52 47,196 
Pension and other postretirement plans:        
Actuarial loss(89,928) (89,928) 
Amortization of net prior service credit included in net income(497)(521)(993)(1,040)
Amortization of net actuarial gain included in net income
(258)(380)(516)(759)
Settlement gain included in net income(136,955) (136,955) 
  (227,638)(901)(228,392)(1,799)
Cash flow hedges gain (loss)640 (364)1,266 (1,043)
Other Comprehensive (Loss) Income, Before Tax(220,698)31,664 (227,074)44,354 
Income tax benefit related to items of other comprehensive (loss) income59,049 326 59,083 732 
Other Comprehensive (Loss) Income, Net of Tax(161,649)31,990 (167,991)45,086 
Comprehensive Income120,727 72,413 145,136 111,230 
Comprehensive income attributable to noncontrolling interests
(1,273)(3,674)(2,918)(5,501)
Total Comprehensive Income Attributable to Graham Holdings Company$119,454 $68,739 $142,218 $105,729 

See accompanying Notes to Condensed Consolidated Financial Statements.
2


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
As of
(in thousands)June 30,
2026
December 31,
2025
  (Unaudited)  
Assets
Current Assets
Cash and cash equivalents$156,766 $266,988 
Restricted cash51,342 44,417 
Investments in marketable equity securities and other investments1,089,301 1,088,970 
Accounts receivable, net474,687 576,754 
Inventories and contracts in progress333,459 303,370 
Prepaid expenses120,751 124,875 
Income taxes receivable33,404 15,447 
Other current assets11,339 10,274 
Total Current Assets2,271,049 2,431,095 
Property, Plant and Equipment, Net577,861 587,434 
Lease Right-of-Use Assets396,165 404,818 
Investments in Affiliates208,550 229,565 
Goodwill, Net1,600,573 1,585,666 
Indefinite-Lived Intangible Assets170,337 170,805 
Amortized Intangible Assets, Net49,409 61,631 
Prepaid Pension Cost2,723,553 2,772,394 
Deferred Income Taxes8,399 9,690 
Deferred Charges and Other Assets135,213 142,615 
Total Assets$8,141,109 $8,395,713 
Liabilities and Equity
Current Liabilities
Accounts payable, vehicle floor plan payable and accrued liabilities$638,583 $721,626 
Deferred revenue292,474 411,651 
Income taxes payable23,352 8,995 
Mandatorily redeemable noncontrolling interest6,033 6,874 
Current portion of lease liabilities61,341 64,290 
Current portion of long-term debt191,472 175,138 
Dividends declared8,040  
Total Current Liabilities1,221,295 1,388,574 
Accrued Compensation and Related Benefits136,740 135,323 
Other Liabilities23,439 28,639 
Deferred Income Taxes850,945 890,984 
Mandatorily Redeemable Noncontrolling Interest1,390 1,527 
Lease Liabilities376,913 377,897 
Long-Term Debt708,901 705,618 
Total Liabilities3,319,623 3,528,562 
Commitments and Contingencies (Note 15)
Redeemable Noncontrolling Interests25,386 39,824 
Preferred Stock  
Common Stockholders’ Equity
Common stock20,000 20,000 
Capital in excess of par value352,983 379,896 
Retained earnings8,578,539 8,292,681 
Accumulated other comprehensive income, net of taxes  
Cumulative foreign currency translation adjustment(12,210)(12,262)
Unrealized gain on pensions and other postretirement plans432,083 601,064 
Cash flow hedges(784)(1,722)
Cost of Class B common stock held in treasury(4,609,033)(4,485,632)
Total Common Stockholders’ Equity4,761,578 4,794,025 
Noncontrolling Interests34,522 33,302 
Total Equity4,796,100 4,827,327 
Total Liabilities and Equity$8,141,109 $8,395,713 
See accompanying Notes to Condensed Consolidated Financial Statements.
3


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
  Six Months Ended 
 June 30
(in thousands)20262025
Cash Flows from Operating Activities    
Net Income$313,127 $66,144 
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and goodwill and other asset impairments67,737 55,271 
Amortization of lease right-of-use asset29,343 28,729 
Net pension benefit, settlement gain and early retirement and special separation benefit expense(179,035)(40,985)
Gain on marketable equity securities and cost method investments, net of impairment(32,956)(19,579)
Loss on disposition of businesses, property, plant and equipment and investments, net4,669 485 
Credit loss expense2,953 2,125 
Stock-based compensation expense, net of forfeitures3,113 3,111 
Foreign exchange loss561 8,854 
Equity in (earnings) losses of affiliates, net of distributions20,028 11,219 
Provision for deferred income taxes17,442 3,079 
Change in operating assets and liabilities:
Accounts receivable80,834 60,739 
Inventories(27,198)33,244 
Accounts payable and accrued liabilities(65,799)(55,264)
Deferred revenue(90,294)(59,192)
Income taxes receivable/payable(4,072)(13,636)
Lease liabilities(24,701)(25,615)
Other assets and other liabilities, net3,240 82,088 
Other1,418 (7)
Net Cash Provided by Operating Activities120,410 140,810 
Cash Flows from Investing Activities    
Proceeds from sales of marketable equity securities49,994  
Net (payment on) proceeds from disposition of businesses, property, plant and equipment and investments(40,050)7,348 
Purchases of property, plant and equipment(39,233)(32,285)
Purchases of marketable equity securities(18,696)(4,823)
Investments in certain businesses, net of cash acquired(18,237)(2,523)
Proceeds from repayment of related party loan16,273  
Other 1,109 966 
Net Cash Used in Investing Activities(48,840)(31,317)
Cash Flows from Financing Activities    
Common shares repurchased(121,985)(3,468)
Purchase of noncontrolling interests(17,340) 
Dividends paid(16,311)(15,660)
Repayments of borrowings(15,194)(13,172)
Net borrowings under revolving credit facilities13,092 75,000 
Net repayments of vehicle floor plan payable(1,863)(32,776)
Principal payments of finance leases(7,543)(8,446)
Distributions paid to noncontrolling interests(4,355)(190,319)
Other(963)329 
Net Cash Used in Financing Activities(172,462)(188,512)
Effect of Currency Exchange Rate Change(2,405)10,514 
Net Decrease in Cash and Cash Equivalents and Restricted Cash(103,297)(68,505)
Beginning Cash and Cash Equivalents and Restricted Cash311,405 297,853 
Ending Cash and Cash Equivalents and Restricted Cash$208,108 $229,348 


See accompanying Notes to Condensed Consolidated Financial Statements.
4


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN COMMON STOCKHOLDERS’ EQUITY (UNAUDITED)
(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2025$20,000 $379,896 $8,292,681 $587,080 $(4,485,632)$33,302 $4,827,327 $39,824 
Net income for the period30,751 30,751 
Net income attributable to noncontrolling interests(699)699  
Net income attributable to redeemable noncontrolling interests(946)(946)946 
Change in redemption value of redeemable noncontrolling interest(8,225)(4)(8,229)8,250 
Distributions to noncontrolling interests(884)(884)(2,251)
Dividends on common stock(16,398)(16,398)
Repurchase of Class B common stock(34,476)(34,476)
Issuance of Class B common stock, net of restricted stock award forfeitures(252)224 (28)
Shares withheld related to net share settlement(434)(434)
Amortization of unearned stock compensation and stock option expense1,525 1,525 
Purchase of noncontrolling interest(26,001)939(25,062)
Other comprehensive loss, net of income taxes(6,342)(6,342)
Purchase of redeemable noncontrolling interests (16,849)
As of March 31, 2026$20,000 $346,943 $8,305,389 $580,738 $(4,520,318)$34,052 $4,766,804 $29,920 
Net income for the period282,376 282,376 
Net income attributable to noncontrolling interests(1,348)1,348  
Net loss attributable to redeemable noncontrolling interests75 75 (75)
Change in redemption value of redeemable noncontrolling interests4,427 210 4,637 (4,427)
Distributions to noncontrolling interests(1,088)(1,088)(32)
Dividends on common stock(7,953)(7,953)
Repurchase of Class B common stock(88,718)(88,718)
Issuance of Class B common stock, net of restricted stock award forfeitures(160)3 (157)
Amortization of unearned stock compensation and stock option expense1,773 1,773 
Other comprehensive loss, net of income taxes(161,649)(161,649)
As of June 30, 2026$20,000 $352,983 $8,578,539 $419,089 $(4,609,033)$34,522 $4,796,100 $25,386 
5


(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2024$20,000 $356,919 $8,031,750 $334,797 $(4,486,805)$30,154 $4,286,815 $43,821 
Net income for the period25,721 25,721 
Net income attributable to noncontrolling interests
(1,129)1,129  
Net income attributable to redeemable noncontrolling interests
(698)(698)698 
Change in redemption value of redeemable noncontrolling interests634 634 8 
Noncontrolling interest capital contribution180 180 
Distributions to noncontrolling interests(747)(747)(941)
Dividends on common stock(15,662)(15,662)
Repurchase of Class B common stock(3,468)(3,468)
Issuance of Class B common stock, net of restricted stock award forfeitures9,431 9,141 18,572 
Shares withheld related to net share settlement(402)(402)
Amortization of unearned stock compensation and stock option expense1,724 1,724 
Other comprehensive income, net of income taxes13,096 13,096 
As of March 31, 2025$20,000 $368,074 $8,039,982 $347,893 $(4,481,534)$31,350 $4,325,765 $43,586 
Net income for the period40,423 40,423 
Net income attributable to noncontrolling interests
(2,030)2,030  
Net income attributable to redeemable noncontrolling interests
(1,644)(1,644)1,644 
Change in redemption value of redeemable noncontrolling interests
(4,971)642 (4,329)4,977 
Distributions to noncontrolling interests(1,371)(1,371)(338)
Dividends on common stock(7,846)(7,846)
Forfeiture of restricted stock awards, net of Class B common stock issuances(6)(124)(130)
Amortization of unearned stock compensation and stock option expense
1,696 1,696 
Other comprehensive income, net of income taxes31,990 31,990 
As of June 30, 2025$20,000 $364,793 $8,068,885 $379,883 $(4,481,658)$32,651 $4,384,554 $49,869 


See accompanying Notes to Condensed Consolidated Financial Statements.
6


GRAHAM HOLDINGS COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. ORGANIZATION, BASIS OF PRESENTATION AND RECENT ACCOUNTING PRONOUNCEMENTS
Graham Holdings Company (the Company), is a diversified holding company whose operations include educational services, television broadcasting, healthcare, manufacturing, automotive dealerships and other businesses.
Through Kaplan, Inc. (Kaplan), the Company provides a wide variety of educational services to students, schools, colleges, universities and businesses, both domestically and outside the United States (U.S.). Kaplan’s educational services include academic preparation programs for international students; operations support services for pre-college, certificate, undergraduate and graduate programs; exam preparation for high school and graduate students and for professional certifications and licensures; career and academic advisement services to businesses; and a United Kingdom (U.K.) sixth-form college that prepares students for A-level examinations.
The Company’s television broadcasting segment owns and operates seven television broadcasting stations and provides social media management tools designed to connect newsrooms with their users.

The Company’s healthcare division provides in-home specialty pharmacy infusion therapies; home health, hospice and palliative services; physician services for allergy, asthma and immunology patients; in-home aesthetics; applied behavior analysis therapy; and healthcare software-as-a-service technology.
The Company’s manufacturing companies include a supplier of pressure-treated wood and aluminum cladding products, a manufacturer of electrical solutions, a manufacturer of lifting solutions, and a supplier of parts used in electric utilities and industrial systems.
The Company’s automotive business comprises eight dealerships and valet repair services.
The Company’s other businesses include restaurants; a custom framing company; a marketing solutions provider; a customer data and analytics software company; Slate and Foreign Policy magazines; a daily local news podcast and newsletter company; a company that provides a software-as-a-service platform that enables podcasters and media companies to monetize audio content through paid subscriptions, memberships, and audiobooks; an online art gallery and in-person art fair business; and an online commerce platform featuring original art and designs on an array of consumer products.
On February 1, 2026, Kaplan entered into a Share Purchase Agreement to sell its Kaplan Languages Group (KLG) business, consisting of more than 20 language schools in eight countries. The transaction closed on May 1, 2026.
Basis of Presentation – The accompanying condensed consolidated financial statements have been prepared in accordance with: (i) generally accepted accounting principles in the United States of America (GAAP) for interim financial information; (ii) the instructions to Form 10-Q; and (iii) the guidance of Rule 10-01 of Regulation S-X under the Securities and Exchange Act of 1934, as amended, for financial statements required to be filed with the Securities and Exchange Commission (SEC). They include the assets, liabilities, results of operations and cash flows of the Company, including its domestic and foreign subsidiaries that are more than 50% owned or otherwise controlled by the Company. As permitted under such rules, certain notes and other financial information normally required by GAAP have been condensed or omitted. Management believes the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary for a fair statement of the Company’s financial position, results of operations, and cash flows as of and for the periods presented herein. The Company’s results of operations for the three and six months ended June 30, 2026 and 2025 may not be indicative of the Company’s future results. These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.
Use of Estimates in the Preparation of the Condensed Consolidated Financial Statements – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported herein. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates.
7


Recently Adopted and Issued Accounting Pronouncements – In November 2024, the Financial Accounting Standards Board (FASB) issued new guidance that requires disclosures about certain significant expense categories including inventory purchases, employee compensation, depreciation, amortization, and selling expenses. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on the disclosures within its Condensed Consolidated Financial Statements.
In September 2025, FASB issued new guidance which updates the accounting for internal-use software by removing references to software development project stages and adding new criteria to determine when an entity is required to start capitalizing internal-use software costs. The guidance is effective for fiscal years and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on its Condensed Consolidated Financial Statements.
2. ACQUISITIONS AND DISPOSITIONS OF BUSINESSES
Acquisitions. In March 2026, the Company acquired one small business which is included in other healthcare businesses. The assets and liabilities of the company acquired were recorded at their estimated fair values at the date of acquisition.
During 2025, the Company acquired five businesses: one in education, two in other healthcare businesses, one in manufacturing and one in automotive for $71.2 million in cash and the assumption of floor plan payables and $107.5 million in net pension obligations. The assets and liabilities of the companies acquired were recorded at their estimated fair values at the date of acquisition.
In June 2025, Kaplan acquired one small business which is included in its supplemental education division.
In July 2025, Hoover acquired 100% of Arconic Architectural Products, LLC, a wholly-owned subsidiary of Arconic Corporation, which manufactures aluminum cladding products and operates within the broader non-residential materials space from its facility in Eastman, GA. A significant portion of the purchase price was funded by the Company’s assumption of certain pension obligations. The acquisition expands Hoover’s product offerings and is included in manufacturing.
In October 2025, Graham Healthcare Group (GHG) acquired two small businesses which are included in other healthcare businesses.
In October 2025, the Company’s automotive subsidiary acquired a Honda automotive dealership, including the real property for the dealership operations. In addition to a cash payment and the assumption of $4.9 million in floor plan payables, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition (see Note 7). The dealership is operated and managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships. This acquisition expands the Company’s automotive business operations and is included in automotive.
Acquisition-related costs for the acquisitions that closed during the first six months of 2026 and 2025 were expensed as incurred. The aggregate purchase price of the 2025 acquisitions was allocated as follows, based on the acquisition date fair values to the following assets and liabilities:
Purchase Price Allocation
Year Ended
(in thousands)December 31, 2025
Accounts receivable$11,641 
Inventory32,731 
Property, plant and equipment35,920 
Lease right-of-use assets3,642 
Goodwill51,943 
Indefinite-lived intangible assets15,500 
Amortized intangible assets41,300 
Deferred income taxes13,947 
Other assets221 
Pension liabilities(107,517)
Floor plan payables(4,939)
Other liabilities(18,371)
Current and noncurrent lease liabilities(4,783)
Aggregate purchase price, net of cash acquired$71,235 
8


Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The goodwill recorded due to these acquisitions is attributable to the assembled workforces of the acquired companies and expected synergies. The Company expects to deduct $12.4 million of goodwill for income tax purposes for the acquisitions completed in 2025.
The acquired companies were consolidated into the Company’s financial statements starting on their respective acquisition dates. The following unaudited pro forma financial information includes the 2025 acquisitions as if they occurred at the beginning of 2024:
Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)20252025
Operating revenues$1,263,248 $2,476,640 
Net income42,008 69,343 
These pro forma results were based on estimates and assumptions, which the Company believes are reasonable, and include the historical results of operations of the acquired companies and adjustments for depreciation and amortization of identified assets and the effect of pre-acquisition transaction related expenses incurred by the Company and the acquired entities. The pro forma information does not include efficiencies, cost reductions and synergies expected to result from the acquisitions. They are not the results that would have been realized had these entities been part of the Company during the periods presented and are not necessarily indicative of the Company’s consolidated results of operations in future periods.
Disposition of Businesses. In May 2026, Kaplan completed the sale of the KLG business, which is included in Kaplan International. As a result of the sale, the Company recorded a non-operating loss of $5.2 million in the second quarter of 2026 (see Note 13). KLG comprised Kaplan International Languages, Alpadia Language Schools, Azurlingua and English as a second language (ESL) Education. The assets and liabilities of KLG had previously been classified as held for sale in the Company’s Condensed Consolidated Balance Sheet as of March 31, 2026.
During the first quarter of 2026, upon classifying the KLG disposal group as held for sale, the Company recognized total impairment charges of $19.0 million, consisting of a $1.0 million goodwill impairment charge and an $18.0 million impairment charge related to the asset group held for sale.
In early September 2025, the Company ceased operations of the Ourisman Jeep of Bethesda dealership.
In April 2025, Kaplan completed the sale of a small business, BridgeU Limited, which was included in Kaplan International.
In the first half of 2025, World of Good Brands (WGB) completed the sale of various websites and related businesses that made up the WGB operations, which were included in other businesses. All remaining WGB operations were substantially shut down by the end of the third quarter of 2025.
Other Transactions. In March 2026, the Company acquired some of the minority-owned shares of CSI Pharmacy Holding Company, LLC (CSI) for a total amount of $41.0 million. The Company paid cash of $16.4 million and entered into promissory notes with the minority owners for the remaining $24.6 million at an interest rate of 8% per annum. The notes are included in other indebtedness (see Note 7) and payable in quarterly installments with the final payment due on April 1, 2028. Following the redemption, the Company owns 93.4% of CSI.
In January 2026, pursuant to the exercise of a put right, the Company purchased some of the minority-owned interest of Clarus for $1.0 million. Following the redemption, the Company owns 97.5% of Clarus.
In October 2025, pursuant to the exercise of a put right, the Company purchased some of the minority-owned interest of Clarus for $0.4 million. Following the redemption, the Company owned 95.75% of Clarus.
In July 2025, CSI exercised its call option to purchase some of the minority-owned interest of CSI for $1.8 million.
On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest related to GHC One LLC (GHC One), including CSI, for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.
The settlement agreement resulted in a $66.2 million increase to the mandatorily redeemable noncontrolling interest obligation, which the Company recorded as interest expense in the first quarter of 2025. The remaining mandatorily redeemable noncontrolling interest obligation related to GHC One and GHC Two LLC (GHC Two) was $7.4 million
9


at June 30, 2026, with $6.0 million included in current liabilities due to the expected dissolution of GHC One within one year.
In December 2024, the Company acquired some of the minority-owned shares of CSI for a total estimated amount of $2.0 million. The Company paid cash of $0.6 million and entered into a promissory note with the minority owner for the remaining $1.4 million at an interest rate of 5.5% per annum. The note was included in other indebtedness (see Note 7) and was due and payable on January 31, 2026. Following the redemption, the Company owned 87.5% of CSI. Pursuant to the terms of the purchase agreement, the purchase price was finalized in December 2025, resulting in an additional amount payable of $0.1 million, plus interest at 5.5% per annum, to the minority owner. The note was subsequently paid in the first quarter of 2026.
As of June 30, 2026, the Company holds a controlling financial interest in GHC One and GHC Two and therefore includes the assets, liabilities, results of operations and cash flows in its consolidated financial statements. GHC One acquired Clarus during 2019. GHC Two acquired Impact Medical during 2021 and Skin Clique and Surpass in 2022. The Company accounts for the minority ownership of the group of current and former senior managers in GHC One and GHC Two as a mandatorily redeemable noncontrolling interest (see Note 8).
3. INVESTMENTS
Money Market Investments. As of June 30, 2026 and December 31, 2025, the Company had money market investments of $7.3 million and $5.3 million, respectively, that are classified as cash and cash equivalents in the Company’s Condensed Consolidated Balance Sheets.
Investments in Marketable Equity Securities. Investments in marketable equity securities consist of the following:
  As of
June 30,
2026
December 31,
2025
(in thousands)
Total cost
$271,013 $256,897 
Gross unrealized gains
828,045 845,889 
Gross unrealized losses(15,966)(20,848)
Total Fair Value
$1,083,092 $1,081,938 
At June 30, 2026 and December 31, 2025, the Company owned 63,793 and 55,430 shares, respectively, in Markel Group Inc. (Markel) valued at $124.6 million and $119.2 million, respectively. The Chief Executive Officer of Markel, Mr. Thomas S. Gayner, is a member of the Company’s Board of Directors. As of June 30, 2026, the Company owned 422 Class A and 481,920 Class B shares in Berkshire Hathaway valued at $557.2 million, which exceeded 5% of the Company’s total assets.
The Company purchased $18.7 million and $4.8 million of marketable equity securities during the first six months of 2026 and 2025, respectively.
During the first six months of 2026, the gross cumulative realized net gains from the sales of marketable equity securities were $45.5 million. The total proceeds from such sales were $50.0 million. The Company donated marketable equity securities in the first six months of 2026 and recorded a $0.5 million gross cumulative realized gain from the donation. There were no sales of marketable equity securities during the first six months of 2025.
The net gain (loss) on marketable equity securities comprised the following:

Three Months Ended 
 June 30

Six Months Ended 
 June 30
(in thousands)
2026202520262025
Gain (loss) on marketable equity securities, net$101,879 $(11,543)$32,956 $32,258 
Less: Net gains in earnings from marketable equity securities sold and donated(44) (2,411) 
Net unrealized gains (losses) in earnings from marketable equity securities still held at the end of the period$101,835 

$(11,543)

$30,545 $32,258 
Investments in Affiliates. As of June 30, 2026, the Company’s healthcare subsidiary held investments in several affiliates that GHG actively manages; GHG held a 40% interest in each of the following affiliates: Residential Home Health Illinois, Residential Hospice Illinois, Mary Free Bed at Home, and Allegheny Health Network Healthcare at Home. For the three and six months ended June 30, 2026, the Company recorded $4.3 million and $8.4 million, respectively, in revenue for services provided to the affiliates of GHG. For the three and six months ended June 30,
10


2025, the Company recorded $4.1 million and $7.9 million, respectively, in revenue for services provided to the affiliates of GHG.
As of June 30, 2026, the Company held a 50.4%, 41.4% and 25.2% interest in N2K Networks, Realm and Intersection, respectively, on a fully diluted basis, and accounts for these investments under the equity method. The Company holds two of the five seats of N2K Networks’ governing board with the other shareholders retaining substantive participation rights to control the financial and operating decisions of N2K Networks through representation on the board. In May 2024, the Company entered into a convertible promissory note agreement to loan N2K Networks $2.0 million. The convertible promissory note bears interest at a rate of 12% per annum and, subject to conversion provisions, all unpaid interest and principal are due by May 2027.
In the second quarter of 2026, the Company recorded an impairment charge of $5.8 million on its investment in Realm following a reduction in the investee’s current and expected growth.
The Company had $28.2 million and $30.0 million in its investment account that represents cumulative undistributed income in its investments in affiliates as of June 30, 2026 and December 31, 2025, respectively.
Additionally, Kaplan International Holdings Limited (KIHL) held a 45% interest in a joint venture formed with University of York. KIHL loaned the joint venture £22 million, which is repayable over 25 years at an interest rate of 7% and guaranteed by the University of York. The outstanding balance on this loan was £18.8 million as of June 30, 2026. The loan is repayable by December 2041.
Cost Method Investments. The Company held investments without readily determinable fair values in a number of equity securities that are accounted for as cost method investments, which are recorded at cost, less impairment, and adjusted for observable price changes for identical or similar investments of the same issuer. The carrying value of these investments was $49.4 million as of June 30, 2026 and December 31, 2025. During the three and six months ended June 30, 2025, the Company recorded impairment losses of $12.7 million to equity securities that are accounted for as cost method investments.
4. ACCOUNTS RECEIVABLE, ACCOUNTS PAYABLE, VEHICLE FLOOR PLAN PAYABLE AND ACCRUED LIABILITIES
Accounts receivable consist of the following:
As of
June 30,
2026
December 31,
2025
(in thousands)
Receivables from contracts with customers, less estimated credit losses of $26,015 and $23,164
$419,481 $519,068 
Other receivables55,206 57,686 
 $474,687 $576,754 
Credit loss expense was $1.5 million and $1.0 million for the three months ended June 30, 2026 and 2025, respectively. Credit loss expense was $3.0 million and $2.1 million for the six months ended June 30, 2026 and 2025, respectively.
Accounts payable, vehicle floor plan payable and accrued liabilities consist of the following:
As of
June 30,
2026
December 31,
2025
(in thousands)
Accounts payable$175,672 $181,009 
Vehicle floor plan payable117,096 118,959 
Accrued compensation and related benefits135,443 194,972 
Other accrued liabilities210,372 226,686 
$638,583 $721,626 
Cash overdrafts of $0.6 million are included in accounts payable as of June 30, 2026 and December 31, 2025.
The Company finances new, used and service loaner vehicle inventory through standardized floor plan facilities with Truist Bank and Toyota Motor Credit Corporation and Ford Motor Credit Company. At June 30, 2026, the floor plan facilities bore interest at variable rates that are based on Secured Overnight Financing Rate (SOFR) and prime-based interest rates. The weighted average interest rate for the floor plan facilities was 5.7% for the three and six months ended June 30, 2026. The weighted average interest rate for the floor plan facilities was 6.3% for the three and six months ended June 30, 2025. The Company incurred floor plan interest expense of $1.8 million and $1.9 million for the three months ended June 30, 2026 and 2025, respectively. The Company incurred floor plan
11


interest expense of $3.5 million and $4.1 million for the six months ended June 30, 2026 and 2025, respectively. Changes in the vehicle floor plan payable are reported as cash flows from financing activities in the Condensed Consolidated Statements of Cash Flows.
The floor plan facilities are collateralized by vehicle inventory and other assets of the relevant dealership subsidiary, and contain a number of covenants, including, among others, covenants restricting the dealership subsidiary with respect to the creation of liens and changes in ownership, officers and key management personnel. The Company was in compliance with all of these restrictive covenants as of June 30, 2026.
The floor plan interest expense related to the vehicle floor plan arrangements is offset by amounts received from manufacturers in the form of floor plan assistance capitalized in inventory and recorded against cost of goods sold in the Condensed Consolidated Statements of Operations when the associated inventory is sold. For the three months ended June 30, 2026 and 2025, the Company recognized a reduction in cost of goods sold of $2.2 million and $2.0 million, respectively, related to manufacturer floor plan assistance. For the six months ended June 30, 2026 and 2025, the Company recognized a reduction in cost of goods sold of $4.1 million and $4.0 million, respectively, related to manufacturer floor plan assistance.
As of June 30, 2026 and December 31, 2025, the Company had $99.8 million and $105.9 million, respectively, in obligations outstanding related to floor plan facilities associated with new vehicles.
5. INVENTORIES AND CONTRACTS IN PROGRESS
Inventories and contracts in progress consist of the following:
As of
June 30,
2026
December 31,
2025
(in thousands)
Raw materials$83,044 $77,977 
Work-in-process14,529 12,906 
Finished goods228,447 209,287 
Contracts in progress7,439 3,200 
 $333,459 $303,370 
6. GOODWILL AND OTHER INTANGIBLE ASSETS
During the first quarter of 2026, in connection with the classification of the KLG disposal group as held for sale, the Company recognized a goodwill impairment charge of $1.0 million at Kaplan International (see Note 2).
Amortization of intangible assets for the three months ended June 30, 2026 and 2025, was $6.0 million and $7.2 million, respectively. Amortization of intangible assets for the six months ended June 30, 2026 and 2025, was $12.0 million and $15.1 million, respectively. Amortization of intangible assets is estimated to be approximately $11 million for the remainder of 2026, $9 million in 2027, $6 million in 2028, $5 million in 2029, $5 million in 2030 and $13 million thereafter.
The changes in the carrying amount of goodwill, by segment, were as follows:
(in thousands)EducationTelevision
Broadcasting
HealthcareManufacturingAutomotiveOther
Businesses
Total
As of December 31, 2025        
Goodwill$1,181,284 $190,815 $136,637 $272,523 $140,832 $108,943 $2,031,034 
Accumulated impairment losses
(331,151)  (82,062) (32,155)(445,368)
850,133 190,815 136,637 190,461 140,832 76,788 1,585,666 
Acquisition  17,996    17,996 
Impairment(976)     (976)
Disposition       
Foreign currency exchange rate changes
(2,113)     (2,113)
As of June 30, 2026        
Goodwill1,178,195 190,815 154,633 272,523 140,832 108,943 2,045,941 
Accumulated impairment losses
(331,151)  (82,062) (32,155)(445,368)
$847,044 $190,815 $154,633 $190,461 $140,832 $76,788 $1,600,573 
12


The changes in carrying amount of goodwill at the Company’s education and healthcare divisions were as follows:
(in thousands)
Kaplan
International
Higher
Education
Supplemental EducationTotal
Education
CSIOther HealthcareTotal Healthcare
As of December 31, 2025      
Goodwill$614,096 $174,564 $392,624 $1,181,284 $87,140 $49,497 $136,637 
Accumulated impairment losses (111,324)(219,827)(331,151)   
614,096 63,240 172,797 850,133 87,140 49,497 136,637 
Acquisition     17,996 17,996 
Impairment(976)  (976)   
Disposition       
Foreign currency exchange rate changes(2,049) (64)(2,113)   
As of June 30, 2026      
Goodwill611,071 174,564 392,560 1,178,195 87,140 67,493 154,633 
Accumulated impairment losses (111,324)(219,827)(331,151)   
$611,071 $63,240 $172,733 $847,044 $87,140 $67,493 $154,633 
Other intangible assets consist of the following:
As of June 30, 2026As of December 31, 2025
(in thousands)Useful Life
Range
Gross
Carrying
Amount
Accumulated
Amortization
Net Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
 Carrying
Amount
Amortized Intangible Assets              
Student and customer relationships
210 years
$296,900 $263,999 $32,901 $307,312 $266,453 $40,859 
Trade names and trademarks
210 years
107,337 94,370 12,967 114,227 98,147 16,080 
Network affiliation agreements
10 years
17,400 16,457 943 17,400 15,588 1,812 
Databases and technology
36 years
30,496 28,568 1,928 32,376 30,293 2,083 
Other
18 years
38,063 37,393 670 38,063 37,266 797 
    $490,196 $440,787 $49,409 $509,378 $447,747 $61,631 
Indefinite-Lived Intangible Assets
              
Franchise agreements$97,002 $97,002 
Trade names and trademarks  62,185     62,653     
FCC licenses11,000 11,000 
Other150 150 
  $170,337 $170,805 
7. DEBT
The Company’s borrowings consist of the following:
  As of
(in thousands)MaturitiesStated Interest RateEffective Interest RateJune 30,
2026
December 31,
2025
Unsecured notes (1)
20335.625%5.625%$493,760 $493,625 
Revolving credit facility2030
5.00% - 7.13%
5.11%231,159 222,466 
Real estate term loan (2)
2028
5.37% - 5.45%
5.48%89,356 91,836 
Capital term loan (3)
2028
6.12% - 6.20%
6.22%60,228 64,079 
Other indebtedness2026 - 2028
6.25% - 8.00%
25,870 8,750 
Total Debt900,373 880,756 
Less: current portion(191,472)(175,138)
Total Long-Term Debt$708,901 $705,618 
___________
(1)     The carrying value is net of $6.2 million and $6.4 million of unamortized debt issuance costs as of June 30, 2026 and December 31, 2025, respectively.
(2)     The carrying value is net of $0.1 million of unamortized debt issuance costs as of June 30, 2026 and December 31, 2025.
(3)     The carrying value is net of $0.4 million and $0.5 million of unamortized debt issuance costs as of June 30, 2026 and December 31, 2025, respectively.
13


On November 24, 2025, the Company issued $500 million of 5.625% unsecured eight-year fixed-rate notes due December 1, 2033 (the Notes). Interest is paid semi-annually on June 1 and December 1. Also on November 24, 2025, the Company used the net proceeds from the sale of the Notes, together with the borrowings under the revolving credit agreement, to (i) redeem the $400 million of 5.75% unsecured notes due June 1, 2026, (ii) refinance outstanding revolving loans under the existing revolving credit facility, and (iii) repay all amounts outstanding under the Company’s existing $150 million term loan. On October 21, 2025, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition of a Honda automotive dealership, including the real property for the dealership operations.
In combination with the issuance of the Notes, the Company amended and restated the Second Amended and Restated Five Year Credit Agreement, dated as of May 3, 2022, to, among other things, (i) increase the Company’s borrowing capacity by replacing the existing revolving commitments with a new revolving credit facility in the aggregate principal amount of $400 million, (ii) extend the maturity of the facility to November 24, 2030, and (iii) increase the letter of credit sublimit to $40 million.
At June 30, 2026 and December 31, 2025, the fair value of the Company’s 5.625% unsecured notes, based on quoted market prices (Level 2 fair value assessment), totaled $496.4 million and $504.0 million, respectively.
The outstanding balance on the Company’s $400 million unsecured revolving credit facility was $231.2 million as of June 30, 2026, consisting of U.S. dollar borrowings of $165.0 million with interest payable at SOFR plus 1.375% or prime rate plus 0.375%, and British Pound borrowings of £50 million with interest payable at Daily Sterling Overnight Index Average (SONIA) plus 1.375%.
The fair value of the Company’s other debt, which is based on Level 2 inputs, approximates its carrying value as of June 30, 2026 and December 31, 2025. The Company is in compliance with all financial covenants of the revolving credit facility and term loans as of June 30, 2026.
During the three months ended June 30, 2026 and 2025, the Company had average borrowings outstanding of approximately $899.4 million and $886.4 million, respectively, at average annual interest rates of approximately 5.7% and 6.0%, respectively. During the three months ended June 30, 2026 and 2025, the Company incurred net interest expense of $15.3 million and $15.8 million, respectively.
During the six months ended June 30, 2026 and 2025, the Company had average borrowings outstanding of approximately $895.5 million and $828.7 million, respectively, at average annual interest rates of approximately 5.7% and 6.0%, respectively. During the six months ended June 30, 2026 and 2025, the Company incurred net interest expense of $29.0 million and $95.6 million, respectively.
During the three and six months ended June 30, 2026, the Company recorded a reduction in interest expense of $0.2 million and $0.9 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. During the three and six months ended June 30, 2025, the Company recorded interest expense of $1.2 million and $67.6 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. The fair value of the mandatorily redeemable noncontrolling interest was based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined by reference to either a discounted cash flow or EBITDA multiple, which approximates fair value (Level 3 fair value assessment) (See Note 2 and 8).
14


8. FAIR VALUE MEASUREMENTS
The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows:
As of June 30, 2026
(in thousands)Level 1Level 2Level 3Total
Assets      
Money market investments (1) 
$ $7,285 $ $7,285 
Marketable equity securities (2)
1,083,092   1,083,092 
Other current investments (3)
 6,209  6,209 
Total Financial Assets
$1,083,092 $13,494 $ $1,096,586 
Liabilities
  
  
  
Interest rate swaps (4) 
$ $1,033 $ $1,033 
Mandatorily redeemable noncontrolling interest (5)
  7,423 7,423 
Total Financial Liabilities
$ $1,033 $7,423 $8,456 

As of December 31, 2025
(in thousands)Level 1Level 2Level 3Total
Assets
  
  

  
Money market investments (1) 
$ $5,251 $ $5,251 
Marketable equity securities (2)
1,081,938   1,081,938 
Other current investments (3)
 7,032  7,032 
Total Financial Assets
$1,081,938 $12,283 $ $1,094,221 
Liabilities
  
  

  
Contingent consideration liabilities (6)
$ $ $1,526 $1,526 
Interest rate swaps (4)
 2,289  2,289 
Mandatorily redeemable noncontrolling interest (5)
  8,401 8,401 
Total Financial Liabilities
$ $2,289 $9,927 $12,216 
____________
(1)
The Company’s money market investments are included in cash and cash equivalents and the value considers the liquidity of the counterparty.
(2)
The Company’s investments in marketable equity securities are held in common shares of U.S. corporations that are actively traded on U.S. stock exchanges. Price quotes for these shares are readily available.
(3)
Includes mutual funds, which are valued using a market approach based on the quoted market prices of the security or inputs that include quoted market prices for similar instruments.
(4)
Included in Other Liabilities. The Company utilized a market approach model using the notional amount of the interest rate swaps multiplied by the observable inputs of time to maturity and market interest rates.
(5)
The fair value of the mandatorily redeemable noncontrolling interest is based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined using enterprise value analyses which include an equal weighing between guideline public company and discounted cash flow analyses.
(6)
Included in Accounts payable, vehicle floor plan payable and accrued liabilities and Other Liabilities. The Company determined the fair value of the contingent consideration liabilities using either a Monte Carlo simulation, Black-Scholes model, or probability-weighted analysis depending on the type of target included in the contingent consideration requirements (revenue, EBITDA, client retention). All analyses included estimated financial projections for the acquired businesses and acquisition-specific discount rates.

15


The following tables provide a reconciliation of changes in the Company’s financial liabilities measured at fair value on a recurring basis, using Level 3 inputs:
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2025
$1,526 $8,401 
Changes in fair value (1)
 (882)
Capital contributions
 4 
Accretion of value included in net income (1)
28  
Settlements or distributions
(299)(100)
Foreign currency exchange rate changes
(2) 
Disposition of business(1,253) 
As of June 30, 2026
$ $7,423 
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2024$1,419 $159,548 
Changes in fair value (1)
 67,560 
Capital contributions
 80 
Accretion of value included in net income (1)
100  
Settlements or distributions
(317)(205,672)
Foreign currency exchange rate changes
147  
As of June 30, 2025$1,349 $21,516 
____________
(1)Changes in fair value and accretion of value of contingent consideration liabilities are included in Selling, general and administrative expenses and the changes in fair value of mandatorily redeemable noncontrolling interest is included in Interest expense in the Company’s Condensed Consolidated Statements of Operations.
Mandatorily Redeemable Noncontrolling Interest. The mandatorily redeemable noncontrolling interest represents the ownership portion of a group of minority shareholders, consisting of a group of current and former senior managers of the healthcare business, in subsidiaries of GHG. The Company established GHC One and GHC Two as vehicles to invest in a portfolio of healthcare businesses together with the group of senior managers of GHG. As the holder of preferred units, the Company is obligated to contribute 95% of the capital required for the acquisition of portfolio investments with the remaining 5% of the capital coming from the group of senior managers. The operating agreements of GHC One and GHC Two require the dissolution of the entities on March 31, 2026, and March 31, 2029, respectively, at which time the net assets will be distributed to its members. As a preferred unit holder, the Company will receive an amount up to its contributed capital plus a preferred annual return of 8% (guaranteed return) after the group of senior managers has received the redemption of their 5% interest in net assets (manager return). All distributions in excess of the manager and guaranteed return will be paid to common unit holders, which currently comprise the group of senior managers of GHG. The Company may convert its preferred units to common units at any time after which it will receive 80% of all distributions in excess of the manager return, with the remaining 20% of excess distributions going to the group of senior managers as holders of the other common units. The mandatorily redeemable noncontrolling interest related to GHC One is reported as a current liability at June 30, 2026 and December 31, 2025 in the Condensed Consolidated Balance Sheets. The mandatorily redeemable noncontrolling interest related to GHC Two is reported as a noncurrent liability at June 30, 2026 and December 31, 2025 in the Condensed Consolidated Balance Sheets.
Other. During the six months ended June 30, 2026, in connection with the sale of the KLG disposal group, the Company recognized total impairment charges of $19.0 million, consisting of a $1.0 million goodwill impairment charge and an $18.0 million impairment charge related to the disposal group. The Company used a market approach to estimate the fair value of KLG disposal group (see Note 2 and 6).
During the three and six months ended June 30, 2026, the Company recorded an impairment charge of $5.8 million on one of its investments in affiliates (see Note 3). The Company used a market approach to determine the estimated fair value of its investment in affiliate.
During the three and six months ended June 30, 2025, the Company recorded impairment losses of $12.7 million to equity securities that are accounted for as cost method investments.
9. INCOME TAXES
The Company recognized a U.S. income tax benefit of $69.6 million during the six months ended June 30, 2026, in connection with the restructuring and sale of the KLG business. No corresponding tax benefit was recognized in any
16


other jurisdiction. The Company continues to monitor relevant developments, including any forthcoming Internal Revenue Service guidance, that could affect the ultimate realization of this benefit.
As a result of the significant U.S. income tax benefit recorded related to the KLG business, the Company has recorded a Pillar Two top-up income tax accrual and expense of $19.2 million. In January 2026, the Organization for Economic Co-operation and Development (OECD) published administrative guidance introducing a Side-by-Side (SbS) Safe Harbor that would effectively exempt U.S. parent multinational groups from Pillar Two top-up tax on their U.S. source income. The SbS Safe Harbor is only effective to the extent participating countries have enacted legislation adopting the guidance. The Company has assessed current law and administrative guidance in relevant non-U.S. jurisdictions. Currently, not all participating countries have enacted legislation to adopt the SbS Safe Harbor, including the U.K. The Company will continue to monitor local implementation and guidance as non-U.S. countries adopt the SbS Safe Harbor into domestic law. The enactment of such legislation in the U.K. and other jurisdictions would have a favorable impact on the Pillar Two top-up tax accrued for 2026, and could result in a complete reversal of the $19.2 million accrued amount without payment.
The Company's effective tax rate for the first six months of 2026 and 2025 was 12.6% and 29.8%, respectively.
10. REVENUE FROM CONTRACTS WITH CUSTOMERS
The Company generated 80% and 79% of its revenue from U.S. domestic sales for the three and six months ended June 30, 2026, respectively. The remaining 20% and 21% of revenue was generated from non-U.S. sales for the three and six months ended June 30, 2026, respectively. For the three and six months ended June 30, 2025, 78% of revenue was from U.S. domestic sales and the remaining 22% of revenue was generated from non-U.S. sales.
For the three and six months ended June 30, 2026, the Company recognized 51% and 52%, respectively, of its revenue over time as control of the services and goods transferred to the customer, and the remaining 49% and 48% at a point in time, when the customer obtained control of the promised goods. For the three and six months ended June 30, 2025, the Company recognized 54% of its revenue over time, and the remaining 46% at a point in time.
Contract Assets. As of June 30, 2026, the Company recognized a contract asset of $33.2 million related to a contract at a Kaplan International business, of which $5.9 million is included in Other current assets and $27.3 million is included in Deferred Charges and Other Assets. The Company expects to recognize an additional $199.8 million related to the remaining performance obligation in the contract over the next three years. As of December 31, 2025, the contract asset was $36.5 million, of which $4.4 million was included in Other current assets and $32.1 million was included in Deferred Charges and Other Assets. Additional contract assets of $2.8 million and $3.0 million are included in Other current assets on the Company’s Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025, respectively.
Deferred Revenue. The Company records deferred revenue when cash payments are received or due in advance of the Company’s performance which includes some payments that are refundable due to the contractual right of the customer to cancel the agreement. As of June 30, 2026 and December 31, 2025, 23% and 22%, respectively, of the Company’s deferred revenue consisted of prepaid amounts which are refundable. The following table presents the change in the Company’s deferred revenue balance:
As of
June 30,
2026
December 31,
2025
%
(in thousands)Change
Deferred revenue$297,288 $418,090 (29)
The majority of the change in the deferred revenue balance is related to the cyclical nature of services in the Kaplan International division and the derecognition of deferred revenue associated with the sale of the KLG businesses in May 2026 (see Note 2). During the six months ended June 30, 2026, the Company recognized $319.0 million related to the Company’s deferred revenue balance as of December 31, 2025, including $59.1 million of prepaid amounts which were refundable at the prior year-end.
Revenue allocated to remaining performance obligations represents deferred revenue amounts that will be recognized as revenue in future periods. As of June 30, 2026, the deferred revenue balance related to certain medical and nursing qualifications with an original contract length greater than twelve months at Kaplan Supplemental Education was $4.1 million. Kaplan Supplemental Education expects to recognize 68% of this revenue over the next twelve months and the remainder thereafter.
17


Costs to Obtain a Contract. The following table presents changes in the Company’s costs to obtain a contract asset:
(in thousands)Balance at
Beginning
of Period
Costs associated with new contractsLess: Costs amortized during the periodOtherBalance
at
End of
Period
2026$42,404 $29,742 $(48,917)$(1,575)$21,654 
The majority of other activity was related to the derecognition of costs to obtain contract assets associated with the sale of the KLG business in May 2026 (see Note 2) and currency translation adjustments for the six months ended June 30, 2026.
11. EARNINGS PER SHARE
The Company’s unvested restricted stock awards contain nonforfeitable rights to dividends and, therefore, are considered participating securities for purposes of computing earnings per share pursuant to the two-class method. The diluted earnings per share computed under the two-class method is lower than the diluted earnings per share computed under the treasury stock method, resulting in the presentation of the lower amount in diluted earnings per share. The computation of the earnings per share under the two-class method excludes the income attributable to the unvested restricted stock awards from the numerator and excludes the dilutive impact of those underlying shares from the denominator.
The following reflects the Company’s net income and share data used in the basic and diluted earnings per share computations using the two-class method:
Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands, except per share amounts)2026202520262025
Numerator:
Numerator for basic earnings per share:
        
Net income attributable to Graham Holdings Company common stockholders
$281,103 $36,749 $310,209 $60,643 
Less: Dividends paid-common stock outstanding and unvested restricted shares
(7,953)(7,846)(24,351)(23,508)
Undistributed earnings
273,150 28,903 285,858 37,135 
Percent allocated to common stockholders99.43 %99.39 %99.43 %99.39 %
271,589 28,726 284,225 36,908 
Add: Dividends paid-common stock outstanding7,908 7,798 24,214 23,364 
Numerator for basic earnings per share
$279,497 $36,524 $308,439 $60,272 
Add: Additional undistributed earnings due to dilutive stock options
16 2 16 2 
Numerator for diluted earnings per share
$279,513 $36,526 $308,455 $60,274 
Denominator:    
Denominator for basic earnings per share:
Weighted average shares outstanding4,265 4,333 4,298 4,327 
Add: Effect of dilutive stock options44 40 44 39 
Denominator for diluted earnings per share
4,309 4,373 4,342 4,366 
Graham Holdings Company Common Stockholders:        
Basic earnings per share
$65.53 $8.43 $71.76 $13.93 
Diluted earnings per share
$64.86 $8.35 $71.04 $13.81 
____________
Earnings per share amounts may not recalculate due to rounding.
18


Diluted earnings per share excludes the following weighted average potential common shares, as the effect would be antidilutive, as computed under the treasury stock method:
Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2026202520262025
Weighted average restricted stock18 13 18 13 
The diluted earnings per share amounts for each of the three and six months ended June 30, 2026 and 2025 excludes the effect of 1,000 contingently issuable shares outstanding as their inclusion would have been antidilutive due to a market condition.
In the three and six months ended June 30, 2026, the Company declared regular dividends totaling $1.88 and $5.64 per common share, respectively. In the three and six months ended June 30, 2025, the Company declared regular dividends totaling $1.80 and $5.40 per common share, respectively.
12. PENSION PLANS
Defined Benefit Plans. The total benefit arising from the Company’s defined benefit pension plans consists of the following components:
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2026202520262025
Service cost$11,922 $11,699 $23,502 $23,891 
Interest cost7,597 6,956 16,292 13,377 
Expected return on assets(44,538)(41,881)(88,818)(83,852)
Amortization of prior service credit(497)(521)(993)(1,040)
Net Periodic Benefit(25,516)(23,747)(50,017)(47,624)
Settlement(136,955) (136,955) 
Early retirement and separation program costs3,837 6,015 7,937 6,639 
Total Benefit$(158,634)$(17,732)$(179,035)$(40,985)
In June 2026, the Company purchased an irrevocable group annuity contract from an insurance company for $113.9 million to settle $124.3 million of the outstanding defined benefit pension obligation related to certain retirees and beneficiaries. The purchase of the group annuity contract was funded from the assets of the Company’s pension plan. As a result of this transaction, the Company was relieved of all responsibility for these pension obligations and the insurance company is now required to pay and administer the retirement benefits owed to approximately 1,080 retirees and beneficiaries, with no change to the amount, timing or form of monthly retirement benefit payments. As a result, the Company remeasured the accumulated and projected benefit obligation as of June 17, 2026 and recorded a one-time pre-tax settlement gain of $137.0 million. The new measurement basis was used for the recognition of the Company’s pension benefit following the remeasurement. The settlement gain is included in non-operating pension and postretirement benefit income on the Condensed Consolidated Statements of Operations.
In the second quarter of 2026, the Company recorded $2.0 million in expenses related to a Voluntary Retirement Incentive Program (VRIP) for certain Dekko employees. Also in the second quarter of 2026, the Company recorded $1.9 million in expenses related to Separation Incentive Programs (SIPs) for certain Kaplan, Graham Media Group (GMG), Code3 and Slate employees. In the first quarter of 2026, the Company recorded $4.1 million in expenses related to SIPs for certain Kaplan, GMG, Joyce, Dekko, Framebridge, Code3, Slate and Corporate employees. The VRIP and SIPs were funded from the assets of the Company’s pension plans.
In the second quarter of 2025, the Company recorded $6.0 million in expenses related to SIPs for certain Kaplan, GMG, WGB, Saatchi Art, Society6, Code3 and Decile employees. In the first quarter of 2025, the Company recorded $0.6 million in expenses related to a SIP for certain WGB employees. These SIPs were funded from the assets of the Company’s pension plans.
19


The total cost arising from the Company’s Supplemental Executive Retirement Plan (SERP) consists of the following components:
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
(in thousands)2026202520262025
Service cost$290 $238 $579 $477 
Interest cost1,155 1,197 2,310 2,394 
Net Periodic Cost$1,445 $1,435 $2,889 $2,871 
Defined Benefit Plan Assets. The Company’s defined benefit pension obligations are funded by a portfolio made up of private investment funds and a relatively small number of stocks and high-quality fixed-income securities that are held by a third-party trustee. The assets of the Company’s pension plans were allocated as follows:
  As of
  June 30,
2026
December 31,
2025
  
U.S. equities64 %63 %
Private investment funds17 %17 %
International equities16 %16 %
U.S. fixed income3 %4 %
  100 %100 %
The Company manages approximately 41% of the pension assets internally, of which the majority is invested in Berkshire Hathaway stock, with the remaining investments in private investment funds, Markel stock, and short-term fixed-income securities. The remaining 59% of plan assets are managed by two investment companies. The goal of the investment managers is to produce moderate long-term growth in the value of these assets, while protecting them against large decreases in value. Both investment managers may invest in a combination of equity and fixed-income securities and cash. The managers are not permitted to invest in securities of the Company or in alternative investments. One investment manager cannot invest more than 15% of the assets at the time of purchase in each of the stocks of Alphabet and Berkshire Hathaway, and no more than 50% of the assets it manages in specified international exchanges at the time the investment is made. The other investment manager cannot invest more than 20% of the assets at the time of purchase in the stock of Berkshire Hathaway and no more than 15% of the assets it manages in specified international exchanges at the time the investment is made. Excluding the exceptions noted above, the investment managers cannot invest more than 10% of the assets in the securities of any other single issuer, except for obligations of the U.S. Government, without receiving prior approval from the Plan administrator.
In determining the expected rate of return on plan assets, the Company considers the relative weighting of plan assets, the historical performance of total plan assets and individual asset classes and economic and other indicators of future performance. In addition, the Company may consult with and consider the input of financial and other professionals in developing appropriate return benchmarks.
The Company evaluated its defined benefit pension plan asset portfolio for the existence of significant concentrations (defined as greater than 10% of plan assets) of credit risk as of June 30, 2026. Types of concentrations that were evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country and individual fund. At June 30, 2026, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $1,232.0 million, or approximately 37% of total plan assets. At December 31, 2025, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $1,267.4 million, or approximately 37% of total plan assets. Assets also included $113.3 million and $124.7 million of Markel shares at June 30, 2026 and December 31, 2025, respectively.
20


13. OTHER NON-OPERATING EXPENSE
A summary of non-operating expense is as follows:

Three Months Ended 
 June 30

Six Months Ended 
 June 30
(in thousands)2026202520262025
(Loss) gain on sales of businesses$(5,151)$371 $(5,151)$371 
Foreign currency gain (loss), net663 (4,475)(561)(8,854)
Gain on sale of cost method investment  484  
Impairment of a cost method investment (12,679) (12,679)
Other gain, net1,957 327 2,269 641 
Total Other Non-Operating Expense$(2,531)$(16,456)$(2,959)$(20,521)
In the second quarter of 2026, the Company recorded a $5.2 million loss related to Kaplan’s sale of KLG (see Note 2).
14. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The other comprehensive income (loss) consists of the following components:
Three Months Ended June 30
  20262025
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$125 $ $125 $32,283 $ $32,283 
Adjustment for sales of businesses with foreign operations6,175  6,175 646  646 
6,300  6,300 32,929  32,929 
Pension and other postretirement plans:            
Actuarial loss(89,928)23,393 (66,535)   
Amortization of net prior service credit included in net income(497)129 (368)(521)133 (388)
Amortization of net actuarial gain included in net income
(258)67 (191)(380)98 (282)
Settlement gain included in net income(136,955)35,625 (101,330)   
(227,638)59,214 (168,424)(901)231 (670)
Cash flow hedges:            
Gain (loss) for the period640 (165)475 (364)95 (269)
Other Comprehensive (Loss) Income$(220,698)$59,049 $(161,649)$31,664 $326 $31,990 
  Six Months Ended June 30
  20262025
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$(6,123)$ $(6,123)$46,550 $ $46,550 
Adjustment for sales of businesses with foreign operations6,175  6,175 646  646 
52  52 47,196  47,196 
Pension and other postretirement plans:            
Actuarial loss(89,928)23,393 (66,535)   
Amortization of net prior service credit included in net income(993)259 (734)(1,040)266 (774)
Amortization of net actuarial gain included in net income
(516)134 (382)(759)195 (564)
Settlement gain included in net income(136,955)35,625 (101,330)   
  (228,392)59,411 (168,981)(1,799)461 (1,338)
Cash flow hedges:          
Gain (loss) for the period1,266 (328)938 (1,043)271 (772)
Other Comprehensive (Loss) Income$(227,074)$59,083 $(167,991)$44,354 $732 $45,086 
21


The accumulated balances related to each component of other comprehensive income (loss) are as follows:
(in thousands, net of taxes)Cumulative
Foreign
Currency
Translation
Adjustment
Unrealized Gain
on Pensions
and Other
Postretirement
Plans
Cash Flow
Hedges
Accumulated
Other
Comprehensive
Income
As of December 31, 2025$(12,262)$601,064 $(1,722)$587,080 
Other comprehensive (loss) income before reclassifications(6,123)(66,535)604 (72,054)
Net amount reclassified from accumulated other comprehensive income (loss)
6,175 (102,446)334 (95,937)
Net other comprehensive (loss) income52 (168,981)938 (167,991)
As of June 30, 2026$(12,210)$432,083 $(784)$419,089 
The amounts and line items of reclassifications out of Accumulated Other Comprehensive Income (Loss) are as follows:
  Three Months Ended 
 June 30
Six Months Ended 
 June 30
Affected Line Item in the Condensed Consolidated Statements of Operations
  
(in thousands)2026202520262025
Foreign Currency Translation Adjustments:          
Adjustment for sales of businesses with foreign operations$6,175 $646 $6,175 $646 Other expense, net
Pension and Other Postretirement Plans:        
Amortization of net prior service credit(497)(521)(993)(1,040)(1)
Amortization of net actuarial gain(258)(380)(516)(759)(1)
Settlement gain(136,955) (136,955) (1)
  (137,710)(901)(138,464)(1,799)Before tax
  35,821 231 36,018 461 Provision for Income Taxes
  (101,889)(670)(102,446)(1,338)Net of Tax
Cash Flow Hedges170 61 334 121 Interest expense
Total reclassification for the period$(95,544)$37 $(95,937)$(571)Net of Tax
____________
(1)    These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and postretirement plan cost (see Note 12) and are included in non-operating pension and postretirement benefit income in the Company’s Condensed Consolidated Statements of Operations.
15. CONTINGENCIES
Litigation, Legal and Other Matters.  The Company and its subsidiaries are subject to complaints and administrative proceedings and are defendants in various civil lawsuits that have arisen in the ordinary course of their businesses, including contract disputes; actions alleging negligence, libel, defamation and invasion of privacy; trademark, copyright and patent infringement; real estate lease and sublease disputes; violations of employment laws and applicable wage and hour laws; and statutory or common law claims involving current and former students and employees. Although the outcomes of the legal claims and proceedings against the Company cannot be predicted with certainty, based on currently available information, management believes that there are no existing claims or proceedings that are likely to have a material effect on the Company’s business, financial condition, results of operations or cash flows. However, based on currently available information, management believes it is reasonably possible that future losses from existing and threatened legal, regulatory and other proceedings in excess of the amounts recorded could reach approximately $20 million.
16. BUSINESS SEGMENTS
The Company has seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, CSI, Manufacturing and Automotive.
As of June 30, 2026, Kaplan had a total outstanding accounts receivable balance of $25.5 million from Purdue Global related to amounts due for reimbursements for services. Included in this total, Kaplan has a $3.7 million short-term receivable balance due from Purdue Global at June 30, 2026 related to the advance of $20.0 million during the initial KU Transaction.

22


The Company’s segment information is as follows:
Three Months Ended June 30, 2026
(in thousands)EducationTelevision BroadcastingHealthcareManufacturingAutomotiveTotal Segments
Operating Revenues$417,808 $109,630 $247,651 $133,280 $301,352 $1,209,721 
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)
93,562 
Intersegment Elimination(777)
Total Consolidated Revenues$1,302,506 
Less: Significant Expenses (2)
Cost of Revenue (3)
159,247 162,496 98,107 254,956 674,806 
Payroll and Fringe Benefits Expense (4)
113,770 27,745 21,086 162,601 
Occupancy Expense25,497 2,009 27,506 
Advertising and Marketing Expense19,569 19,569 
Networking and Programming Expense29,846 29,846 
Management Services (5)
2,325 2,325 
Other Segment Items (6)
38,875 16,232 56,899 20,037 10,918 142,961 
Earnings Before Interest, Income Taxes, Depreciation, Amortization and Pension Service Cost (EBITDAP)$60,850 $35,807 $28,256 $15,136 $10,058 $150,107 
Pension Service Cost4,672 1,619 1,643 1,255 51 9,240 
Depreciation Expense5,659 2,345 1,913 3,037 1,937 14,891 
Income from Operations before Amortization of Intangible Assets$50,519 $31,843 $24,700 $10,844 $8,070 $125,976 
Other Businesses (7)
(16,650)
Corporate Costs(19,714)
Amortization of Intangible Assets(5,978)
Income from Operations$83,634 
Equity in Losses of Affiliates, Net(19,863)
Interest Expense, Net(15,292)
Non-Operating Pension and Postretirement Benefit Income, Net169,649 
Gain on Marketable Equity Securities, Net101,879 
Other Expense, Net(2,531)
Income Before Income Taxes$317,476 
Capital Expenditures$4,003 $1,758 $3,568 $2,391 $666 $12,386 
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)
7,364 
Total Capital Expenditures$19,750 
(1)Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker (CODM).
(3)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)Other segment items for each reportable segment include:
(a)Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other general and administrative (G&A) expenses.
(b)Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other selling, general and administrative (SG&A) expenses.
(c)Healthcare - indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
(d)Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
(e)Automotive - advertising and marketing expense and other G&A expenses.
(7)Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
23


The Company’s education division segment information is as follows:
Three Months Ended June 30, 2026
(in thousands)Kaplan InternationalHigher EducationSupplemental EducationKaplan Corporate and OtherIntersegment EliminationTotal Education
Operating Revenues$252,375 $86,293 $79,476 $284 $(620)$417,808 
Less: Significant Expenses (1)
Cost of Revenue (2)
85,092 61,158 13,220 (223)159,247 
Payroll and Fringe Benefits Expense (3)
72,089 3,962 32,701 5,101 (83)113,770 
Occupancy Expense24,436 159 808 363 (269)25,497 
Advertising and Marketing Expense7,320 1,919 10,202 128 19,569 
Other Segment Items (4)
25,914 115 11,243 1,919 (316)38,875 
EBITDAP
$37,524 $18,980 $11,302 $(7,227)$271 $60,850 
Pension Service Cost50 2,032 2,060 530 4,672 
Depreciation Expense4,611 300 738 10 5,659 
Income (Loss) from Operations before Amortization of Intangible Assets$32,863 $16,648 $8,504 $(7,767)$271 $50,519 
Capital Expenditures$2,940 $601 $457 $5 $4,003 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)Other segment items for each reportable segment include:
(a)Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
(b)Higher education - training and employment expense, operating fees and other G&A expenses.
(c)Supplemental education - training and employment expense, operating fees and other G&A expenses.
The Company’s healthcare division segment information is as follows:
Three Months Ended June 30, 2026
(in thousands)CSIOther HealthcareTotal Healthcare
Operating Revenues$148,523 $99,128 $247,651 
Less: Significant Expenses (1)
Cost of Revenue (2)
115,040 47,456 162,496 
Other Segment Items (3)
20,664 36,235 56,899 
EBITDAP
$12,819 $15,437 $28,256 
Pension Service Cost 1,643 1,643 
Depreciation Expense301 1,612 1,913 
Income from Operations before Amortization of Intangible Assets$12,518 $12,182 $24,700 
Capital Expenditures$1,220 $2,348 $3,568 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
24


The Company’s segment information is as follows:
Three Months Ended June 30, 2025
(in thousands)EducationTelevision BroadcastingHealthcareManufacturingAutomotiveTotal Segments
Operating Revenues$436,813 $105,984 $202,219 $96,218 $285,572 $1,126,806 
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)
89,591 
Intersegment Elimination(625)
Total Consolidated Revenues$1,215,772 
Less: Significant Expenses (2)
Cost of Revenue (3)
159,017 121,952 65,368 241,639 587,976 
Payroll and Fringe Benefits Expense (4)
120,627 26,818 19,627 167,072 
Occupancy Expense29,024 1,857 30,881 
Advertising and Marketing Expense21,191 21,191 
Networking and Programming Expense31,207 31,207 
Management Services (5)
2,059 2,059 
Other Segment Items (6)
47,245 14,502 51,337 17,545 9,363 139,992 
EBITDAP
$59,709 $33,457 $28,930 $13,305 $11,027 $146,428 
Pension Service Cost4,413 1,532 1,993 654 21 8,613 
Depreciation Expense7,412 2,625 1,723 2,654 1,708 16,122 
Income from Operations before Amortization of Intangible Assets$47,884 $29,300 $25,214 $9,997 $9,298 $121,693 
Other Businesses (7)
(25,666)
Corporate Costs(16,035)
Amortization of Intangible Assets(7,241)
Income from Operations$72,751 
Equity in Earnings of Affiliates, Net3,114 
Interest Expense, Net(15,845)
Non-Operating Pension and Postretirement Benefit Income, Net28,602 
Loss on Marketable Equity Securities, Net(11,543)
Other Expense, Net(16,456)
Income Before Income Taxes$60,623 
Capital Expenditures$5,376 $1,284 $4,449 $2,686 $1,492 $15,287 
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)
4,533 
Total Capital Expenditures$19,820 
(1)Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(3)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)Other segment items for each reportable segment include:
(a)Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other G&A expenses.
(b)Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other SG&A expenses.
(c)Healthcare - indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
(d)Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
(e)Automotive - advertising and marketing expense and other G&A expenses.
(7)Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
25


The Company’s education division segment information is as follows:
Three Months Ended June 30, 2025
(in thousands)Kaplan InternationalHigher EducationSupplemental EducationKaplan Corporate and OtherIntersegment EliminationTotal Education
Operating Revenues$272,171 $84,738 $80,161 $23 $(280)$436,813 
Less: Significant Expenses (1)
Cost of Revenue (2)
89,421 56,721 13,117 (242)159,017 
Payroll and Fringe Benefits Expense (3)
76,656 5,242 33,345 5,406 (22)120,627 
Occupancy Expense27,540 184 1,228 72 29,024 
Advertising and Marketing Expense8,758 2,131 10,180 122 21,191 
Other Segment Items (4)
33,320 216 12,282 1,428 (1)47,245 
EBITDAP
$36,476 $20,244 $10,009 $(7,005)$(15)$59,709 
Pension Service Cost146 1,889 1,972 406 4,413 
Depreciation Expense6,393 383 631 5 7,412 
Income (Loss) from Operations before Amortization of Intangible Assets$29,937 $17,972 $7,406 $(7,416)$(15)$47,884 
Capital Expenditures$3,713 $492 $1,164 $7 $5,376 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)Other segment items for each reportable segment include:
(a)Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
(b)Higher education - training and employment expense, operating fees and other G&A expenses.
(c)Supplemental education - training and employment expense, operating fees and other G&A expenses.
The Company’s healthcare division segment information is as follows:
Three Months Ended June 30, 2025
(in thousands)CSIOther HealthcareTotal Healthcare
Operating Revenues$113,415 $88,804 $202,219 
Less: Significant Expenses (1)
Cost of Revenue (2)
82,047 39,905 121,952 
Other Segment Items (3)
17,154 34,183 51,337 
EBITDAP
$14,214 $14,716 $28,930 
Pension Service Cost 1,993 1,993 
Depreciation Expense183 1,540 1,723 
Income from Operations before Amortization of Intangible Assets$14,031 $11,183 $25,214 
Capital Expenditures$238 $4,211 $4,449 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
26


The Company’s segment information is as follows:
Six Months Ended June 30, 2026
(in thousands)EducationTelevision BroadcastingHealthcareManufacturingAutomotiveTotal Segments
Operating Revenues$858,287 $221,183 $456,991 $258,314 $568,976 $2,363,751 
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)
176,161 
Intersegment Elimination(1,414)
Total Consolidated Revenues$2,538,498 
Less: Significant Expenses (2)
Cost of Revenue (3)
326,674 296,432 186,321 481,699 1,291,126 
Payroll and Fringe Benefits Expense (4)
231,427 55,030 41,078 327,535 
Occupancy Expense52,874 4,041 56,915 
Advertising and Marketing Expense38,998 38,998 
Networking and Programming Expense59,969 59,969 
Management Services (5)
4,617 4,617 
Other Segment Items (6)
85,246 31,250 110,981 40,749 20,308 288,534 
EBITDAP
$123,068 $74,934 $49,578 $31,244 $17,233 $296,057 
Pension Service Cost9,111 3,107 3,529 2,485 68 18,300 
Depreciation Expense11,713 4,681 3,827 6,172 3,782 30,175 
Income from Operations before Amortization of Intangible Assets and Impairment of Goodwill and Asset Group Held for Sale$102,244 $67,146 $42,222 $22,587 $13,383 $247,582 
Other Businesses (7)
(40,250)
Corporate Costs(34,803)
Amortization of Intangible Assets(12,033)
Impairment of Goodwill and Asset Group Held for Sale(19,029)
Income from Operations$141,467 
Equity in Earnings of Affiliates, Net14,987 
Interest Expense, Net(29,046)
Non-Operating Pension and Postretirement Benefit Income, Net200,722 
Gain on Marketable Equity Securities, Net32,956 
Other Expense, Net(2,959)
Income Before Income Taxes$358,127 
Capital Expenditures$8,453 $4,694 $5,733 $4,079 $6,799 $29,758 
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)
10,861 
Total Capital Expenditures$40,619 
(1)Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(3)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)Other segment items for each reportable segment include:
(a)Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other G&A expenses.
(b)Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other SG&A expenses.
(c)Healthcare - indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
(d)Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
(e)Automotive - advertising and marketing expense and other G&A expenses.
(7)Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
27


The Company’s education division segment information is as follows:
Six Months Ended June 30, 2026
(in thousands)Kaplan InternationalHigher EducationSupplemental EducationKaplan Corporate and OtherIntersegment EliminationTotal Education
Operating Revenues$524,011 $178,696 $156,340 $555 $(1,315)$858,287 
Less: Significant Expenses (1)
Cost of Revenue (2)
175,093 127,401 24,742 (562)326,674 
Payroll and Fringe Benefits Expense (3)
148,481 7,767 65,733 9,603 (157)231,427 
Occupancy Expense50,714 317 1,642 737 (536)52,874 
Advertising and Marketing Expense15,519 3,839 19,419 221 38,998 
Other Segment Items (4)
60,199 516 23,426 1,155 (50)85,246 
EBITDAP
$74,005 $38,856 $21,378 $(11,161)$(10)$123,068 
Pension Service Cost176 3,952 4,046 937 9,111 
Depreciation Expense9,579 567 1,548 19 11,713 
Income (Loss) from Operations before Amortization of Intangible Assets and Impairment of Goodwill and Other Long-lived Assets $64,250 $34,337 $15,784 $(12,117)$(10)$102,244 
Capital Expenditures$6,240 $1,416 $792 $5 $8,453 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)Other segment items for each reportable segment include:
(a)Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
(b)Higher education - training and employment expense, operating fees and other G&A expenses.
(c)Supplemental education - training and employment expense, operating fees and other G&A expenses.
The Company’s healthcare division segment information is as follows:
Six Months Ended June 30, 2026
(in thousands)CSIOther HealthcareTotal Healthcare
Operating Revenues$266,304 $190,687 $456,991 
Less: Significant Expenses (1)
Cost of Revenue (2)
206,184 90,248 296,432 
Other Segment Items (3)
40,675 70,306 110,981 
EBITDAP
$19,445 $30,133 $49,578 
Pension Service Cost 3,529 3,529 
Depreciation Expense594 3,233 3,827 
Income from Operations before Amortization of Intangible Assets$18,851 $23,371 $42,222 
Capital Expenditures$2,787 $2,946 $5,733 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
28


The Company’s segment information is as follows:
Six Months Ended June 30, 2025
(in thousands)EducationTelevision BroadcastingHealthcareManufacturingAutomotiveTotal Segments
Operating Revenues$861,544 $209,538 $375,960 $194,223 $566,563 $2,207,828 
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)
175,108 
Intersegment Elimination(1,249)
Total Consolidated Revenues$2,381,687 
Less: Significant Expenses (2)
Cost of Revenue (3)
325,104 222,067 135,105 481,946 1,164,222 
Payroll and Fringe Benefits Expense (4)
233,947 54,582 39,056 327,585 
Occupancy Expense56,946 3,728 60,674 
Advertising and Marketing Expense40,411 40,411 
Networking and Programming Expense62,564 62,564 
Management Services (5)
4,111 4,111 
Other Segment Items (6)
91,288 29,130 101,743 34,123 18,442 274,726 
EBITDAP
$113,848 $63,262 $52,150 $24,995 $19,280 $273,535 
Pension Service Cost8,636 2,951 4,992 1,730 48 18,357 
Depreciation Expense15,176 5,253 3,509 5,357 3,437 32,732 
Income from Operations before Amortization of Intangible Assets$90,036 $55,058 $43,649 $17,908 $15,795 $222,446 
Other Businesses (7)
(55,113)
Corporate Costs(32,044)
Amortization of Intangible Assets(15,065)
Income from Operations$120,224 
Equity in Losses of Affiliates, Net(5,314)
Interest Expense, Net(95,622)
Non-Operating Pension and Postretirement Benefit Income, Net63,219 
Gain on Marketable Equity Securities, Net32,258 
Other Expense, Net(20,521)
Income Before Income Taxes$94,244 
Capital Expenditures$10,117 $1,482 $5,066 $6,059 $1,972 $24,696 
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)
9,227 
Total Capital Expenditures$33,923 
(1)Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(3)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)Other segment items for each reportable segment include:
(a)Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other G&A expenses.
(b)Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other SG&A expenses.
(c)Healthcare - indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
(d)Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
(e)Automotive - advertising and marketing expense and other G&A expenses.
(7)Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
29


The Company’s education division segment information is as follows:
Six Months Ended June 30, 2025
(in thousands)Kaplan InternationalHigher EducationSupplemental EducationKaplan Corporate and OtherIntersegment EliminationTotal Education
Operating Revenues$533,427 $173,225 $155,564 $35 $(707)$861,544 
Less: Significant Expenses (1)
Cost of Revenue (2)
177,518 123,383 24,872 (669)325,104 
Payroll and Fringe Benefits Expense (3)
147,322 9,719 66,512 10,416 (22)233,947 
Occupancy Expense54,565 360 1,886 135 56,946 
Advertising and Marketing Expense16,943 4,008 19,210 250 40,411 
Other Segment Items (4)
63,852 440 24,467 2,493 36 91,288 
EBITDAP
$73,227 $35,315 $18,617 $(13,259)$(52)$113,848 
Pension Service Cost286 3,697 3,859 794 8,636 
Depreciation Expense12,942 839 1,384 11 15,176 
Income (Loss) from Operations before Amortization of Intangible Assets$59,999 $30,779 $13,374 $(14,064)$(52)$90,036 
Capital Expenditures$6,500 $665 $2,945 $7 $10,117 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)Other segment items for each reportable segment include:
(a)Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
(b)Higher education - training and employment expense, operating fees and other G&A expenses.
(c)Supplemental education - training and employment expense, operating fees and other G&A expenses.
The Company’s healthcare division segment information is as follows:
Six Months Ended June 30, 2025
(in thousands)CSIOther HealthcareTotal Healthcare
Operating Revenues$203,663 $172,297 $375,960 
Less: Significant Expenses (1)
Cost of Revenue (2)
146,021 76,046 222,067 
Other Segment Items (3)
33,576 68,167 101,743 
EBITDAP
$24,066 $28,084 $52,150 
Pension Service Cost 4,992 4,992 
Depreciation Expense359 3,150 3,509 
Income from Operations before Amortization of Intangible Assets$23,707 $19,942 $43,649 
Capital Expenditures$536 $4,530 $5,066 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
30


Asset information for the Company’s business segments is as follows:
 As of
(in thousands)June 30, 2026December 31, 2025
Identifiable Assets  
Kaplan international$1,312,886 $1,551,682 
Higher education115,230 174,738 
Supplemental education231,555 247,181 
Kaplan corporate and other28,364 34,973 
Education1,688,035 2,008,574 
Television broadcasting381,276 393,097 
CSI201,786 128,170 
Other healthcare194,926 227,457 
Healthcare396,712 355,627 
Manufacturing553,100 535,006 
Automotive587,305 582,715 
Total Segments3,606,428 3,875,019 
Other businesses366,190 357,408 
Corporate office153,296 79,389 
Investments in Marketable Equity Securities1,083,092 1,081,938 
Investments in Affiliates208,550 229,565 
Prepaid Pension Cost2,723,553 2,772,394 
Total Assets$8,141,109 $8,395,713 
31


Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition.
This analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto.
Results of Operations
The Company reported net income attributable to common shares of $281.1 million ($64.86 per share) for the second quarter of 2026, compared to $36.7 million ($8.35 per share) for the second quarter of 2025.
Items included in the Company’s net income for the second quarter of 2026:
a $137.0 million settlement gain related to a retiree annuity pension purchase (after-tax impact of $101.3 million, or $23.38 per share);
$3.8 million in non-operating expenses related to Separation Incentive Programs (SIPs) and a Voluntary Retirement Incentive Program (VRIP) at the education, television broadcasting and manufacturing divisions, and other businesses (after-tax impact of $2.8 million, or $0.66 per share);
$0.2 million in interest income to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $0.2 million, or $0.05 per share);
$101.9 million in net gains on marketable equity securities (after-tax impact of $75.9 million, or $17.50 per share);
$17.9 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $13.3 million, or $3.08 per share);
a $5.2 million loss on the sale of Kaplan Languages Group (KLG) (after-tax impact of $10.4 million, or $2.41 per share);
a non-operating loss of $5.8 million from the impairment of an equity method investment (after-tax impact of $4.3 million, or $1.00 per share);
a $69.6 million income tax benefit related to the KLG business ($16.05 per share); and
$19.2 million in income tax expense recorded in connection with global minimum corporate income tax obligations in non-U.S. jurisdictions ($4.43 per share).
Items included in the Company’s net income for the second quarter of 2025:
$6.0 million in non-operating expenses related to SIPs at other businesses and the education and television broadcasting divisions (after-tax impact of $4.5 million, or $1.02 per share);
$1.2 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $3.5 million, or $0.79 per share);
$11.5 million in net losses on marketable equity securities (after-tax impact of $8.6 million, or $1.95 per share);
$0.4 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $0.3 million, or $0.07 per share); and
a non-operating loss of $12.7 million from the impairment of a cost method investment (after-tax impact of $9.5 million, or $2.15 per share).
Revenue for the second quarter of 2026 was $1,302.5 million, up 7% from $1,215.8 million in the second quarter of 2025. Revenues increased at television broadcasting, healthcare, manufacturing, automotive and other businesses, partially offset by a decline at education. The Company reported operating income of $83.6 million for the second quarter of 2026, compared to $72.8 million for the second quarter of 2025. The increase in operating results is due to improved results at education, television broadcasting and other businesses, partially offset by declines at healthcare, manufacturing and automotive.
For the first six months of 2026, the Company reported net income attributable to common shares of $310.2 million ($71.04 per share), compared to $60.6 million ($13.81 per share) for the first six months of 2025.
32


Items included in the Company’s net income for the first six months of 2026:
$24.2 million of impairment charges and loss on sale related to KLG (after-tax impact of $24.8 million, or $5.67 per share);
a $137.0 million settlement gain related to a retiree annuity pension purchase (after-tax impact of $101.3 million, or $23.21 per share);
$7.9 million in non-operating expenses related to SIPs and a VRIP at education, television broadcasting and manufacturing divisions, other businesses and the corporate office (after-tax impact of $5.9 million, or $1.34 per share);
$0.9 million in interest income to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $0.8 million, or $0.17 per share);
$33.0 million in net gains on marketable equity securities (after-tax impact of $24.5 million, or $5.62 per share);
$13.1 million in net earnings of affiliates whose operations are not managed by the Company (after-tax impact of $9.7 million, or $2.23 per share);
net non-operating gains of $5.3 million from earnings, sales and impairments of equity and cost method investments (after-tax impact of $4.0 million, or $0.91 per share);
a $69.6 million income tax benefit related to the KLG business ($15.93 per share); and
$19.2 million in income tax expense recorded in connection with global minimum income tax obligations in non- U.S. jurisdictions ($4.39 per share).
Items included in the Company’s net income for the first six months of 2025:
$6.6 million in non-operating expenses related to a SIPs at other businesses and the education and television broadcasting divisions (after-tax impact of $4.9 million, or $1.12 per share);
$67.6 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $53.9 million, or $12.26 per share);
$32.3 million in net gains on marketable equity securities (after-tax impact of $24.0 million, or $5.46 per share);
$12.3 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $9.2 million, or $2.09 per share); and
a non-operating loss of $12.7 million from the impairment of a cost method investment (after-tax impact of $9.5 million, or $2.16 per share).
Revenue for the first six months of 2026 was $2,538.5 million, up 7% from $2,381.7 million in the first six months of 2025. Revenues increased at television broadcasting, healthcare, manufacturing, automotive and other businesses, partially offset by a slight decline at education. The Company reported operating income of $141.5 million for the first six months of 2026, compared to $120.2 million for the first six months of 2025. The increase in operating results is due to improved results at television broadcasting, manufacturing and other businesses, partially offset by declines at education, healthcare and automotive.
Division Results
Education
Education division revenue totaled $417.8 million for the second quarter of 2026, down 4% from $436.8 million for the same period of 2025. Kaplan reported operating income of $50.3 million for the second quarter of 2026, compared to $46.2 million for the second quarter of 2025.
For the first six months of 2026, education division revenue totaled $858.3 million, down slightly from $861.5 million for the same period of 2025. Kaplan reported operating income of $82.7 million for the first six months of 2026, compared to $86.2 million for the first six months of 2025.
33


A summary of Kaplan’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20262025% Change20262025% Change
Revenue            
Kaplan international$252,375 $272,171 (7)$524,011 $533,427 (2)
Higher education86,293 84,738 178,696 173,225 
Supplemental education79,476 80,161 (1)156,340 155,564 
Kaplan corporate and other284 23 — 555 35 — 
Intersegment elimination(620)(280)— (1,315)(707)— 
  $417,808 $436,813 (4)$858,287 $861,544 
Operating Income (Loss)            
Kaplan international$32,863 $29,937 10 $64,250 $59,999 
Higher education16,648 17,972 (7)34,337 30,779 12 
Supplemental education8,504 7,406 15 15,784 13,374 18 
Kaplan corporate and other(7,767)(7,416)(5)(12,117)(14,064)14 
Amortization of intangible assets(243)(1,699)86 (557)(3,818)85 
Impairment of goodwill and asset group held for sale — — (19,029)— — 
Intersegment elimination271 (15)— (10)(52)— 
  $50,276 $46,185 $82,658 $86,218 (4)
In the first quarter of 2026, the Company entered into an agreement to sell KLG included in Kaplan International and recorded a $19.0 million pre-tax impairment charge. Excluding the impairment charge, Kaplan’s operating income was up significantly in the first six months of 2026. The transaction closed on May 1, 2026 and the Company recorded a $5.2 million non-operating pre-tax loss on the sale of the business in the second quarter of 2026.
Kaplan International includes postsecondary education and professional training businesses largely outside the United States (U.S.). Kaplan International revenue decreased 7% for the second quarter of 2026 (10% decrease on a constant currency basis) and decreased 2% for the first six months of 2026 (7% decrease on a constant currency basis) due to the sale of KLG and declines at Pathways, partially offset by increases at Singapore and UK Professional. Kaplan International reported operating income of $32.9 million in the second quarter of 2026, compared to $29.9 million in the second quarter of 2025. Operating income increased to $64.3 million in the first six months of 2026, compared to $60.0 million in the first six months of 2025. Operating results at Singapore, Kaplan Open Learning, UK Professional and Australia grew as a result of strong enrollment growth. The increase was partially offset by broad declines at the Pathways businesses in the United Kingdom (U.K.), Australia and the U.S.
Higher Education includes the results of Kaplan as a service provider to higher education institutions. Higher Education revenue increased 2% and 3% for the second quarter and first six months of 2026, respectively, due primarily to an increase in the Purdue Global fee recorded. Enrollments at Purdue Global, the largest institutional client, increased 5% for the first six months of 2026 compared to the first six months of 2025. For the second quarters and first six months of 2026 and 2025, Kaplan recorded the full fee from Purdue Global. The Company will continue to assess the fee it records from Purdue Global on a quarterly basis to make a determination as to whether to record all or part of the fee in the future and whether to adjust fee amounts recognized in earlier periods. Higher Education operating results declined in the second quarter of 2026, as operating results in the second quarter of 2025 included a portion of the Purdue Global full fee recognition related to the first quarter of 2025. Higher Education operating results improved in the first six months of 2026 due to an increase in the Purdue Global fee recorded, and a decline in higher education development costs.
Supplemental Education includes Kaplan’s standardized test preparation programs and domestic professional and other continuing education businesses. Supplemental Education revenue was up slightly in the first half of 2026 due to growth in some of its professional preparation program offerings, offset by softness in publishing sales volume. Operating results increased in the second quarter and first six months of 2026 from improved margins.
Kaplan corporate and other represents unallocated expenses of Kaplan’s corporate office, other minor businesses and certain shared activities.
In the second quarter of 2026, the Company offered a SIP to certain employees at Supplemental Education, Higher Education, Kaplan International and Kaplan corporate; $1.2 million in related non-operating pension expense was recorded in the second quarter of 2026. In the first quarter of 2026, the Company offered a SIP to certain employees at Kaplan International, Higher Education and Supplemental Education; $1.9 million in related non-operating pension expense was recorded in the first quarter of 2026. In the second quarter of 2025, the Company offered a SIP to certain employees at Higher Education and Supplemental Education; $0.7 million in related non-operating
34


pension expense was recorded in the second quarter of 2025. These programs were funded from the assets of the Company’s pension plan.
Television Broadcasting
A summary of television broadcasting’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20262025% Change20262025% Change
Revenue$109,630 $105,984 $221,183 $209,538 
Operating Income30,483 27,940 64,426 52,338 23 
Graham Media Group owns seven television stations located in Houston, TX; Detroit, MI; Orlando, FL; San Antonio, TX; Jacksonville, FL; and Roanoke, VA, as well as SocialNewsDesk, a provider of social media management tools designed to connect newsrooms with their users.
Revenue at the television broadcasting division increased 3% to $109.6 million in the second quarter of 2026, from $106.0 million in the same period of 2025. The revenue increase is due to an $8.5 million increase in political advertising revenue, partially offset by a $2.3 million decrease in retransmission revenue and declines in local and digital advertising revenue. Operating income for the second quarter of 2026 was up 9% to $30.5 million, from $27.9 million in the same period of 2025, due to higher revenues.
Revenue at the television broadcasting division was up 6% to $221.2 million in the first six months of 2026, from $209.5 million in the same period of 2025. The revenue increase is due to a $15.8 million increase in political advertising revenue and increases from winter Olympics and Super Bowl advertising revenue at the Company’s NBC affiliates in the first quarter of 2026, partially offset by a $5.2 million decrease in retransmission revenue. Operating income for the first six months of 2026 was up 23% to $64.4 million, from $52.3 million in the same period of 2025, due to higher revenues.
While per subscriber rates from cable, satellite and OTT providers have grown, overall cable and satellite subscribers are down due to cord cutting, resulting in retransmission revenue net of network fees in 2026 expected to decline compared with 2025, and this trend is expected to continue.
In the first and second quarters of 2026, the Company offered SIPs to certain employees at the television broadcasting division; $0.6 million and $0.3 million, respectively, in related non-operating pension expense was recorded. In the second quarter of 2025, the Company offered a SIP to certain employees at the television broadcasting division; $0.1 million in related non-operating pension expense was recorded. These programs were funded from the assets of the Company’s pension plan.
In May 2026, the Company’s television station in Orlando (WKMG) entered into a new network affiliation agreement with CBS that covers the period July 1, 2026 through December 31, 2027. In March 2026, the Company’s television station in San Antonio (KSAT) entered into a new network affiliation agreement with ABC that covers the period April 1, 2026 through March 31, 2030.
Healthcare
Healthcare division revenue totaled $247.7 million for the second quarter of 2026, up 22% from $202.2 million for the same period of 2025. Healthcare reported operating income of $24.6 million for the second quarter of 2026, compared to $25.1 million for the second quarter of 2025.
Healthcare division revenue totaled $457.0 million for the first six months of 2026, up 22% from $376.0 million for the same period of 2025. Healthcare reported operating income of $42.0 million for the first six months of 2026, compared to $43.4 million for the same period of 2025.
35


A summary of healthcare division’s operating results is as follows:
  Three Months EndedSix Months Ended  
June 30June 30
(in thousands)20262025% Change20262025% Change
Revenue
CSI$148,523 $113,415 31 $266,304 $203,663 31 
Other Healthcare99,128 88,804 12 190,687 172,297 11 
$247,651 $202,219 22 $456,991 $375,960 22 
Operating Income
CSI$12,498 $13,997 (11)$18,810 $23,640 (20)
Other Healthcare12,112 11,100 23,226 19,774 17 
$24,610 $25,097 (2)$42,036 $43,414 (3)
The healthcare group provides nursing care and prescription services for patients receiving in-home infusion treatments through its 93.4% interest in CSI Pharmacy Holding Company, LLC (CSI). In August 2025, CSI purchased Pine Drug Holdings, LLC and was issued a California pharmacy license, with dispensing operations commencing late in the fourth quarter of 2025. CSI revenue increased 31% in both the second quarter and first six months of 2026 from continued expansion of treatment offerings and patient service areas. Operating results were down in the second quarter and first six months of 2026 due to various operational investments including expanding CSI’s pharmacy facility locations; lower operating margins for certain products compared with the second quarter and first six months of 2025; and increased incentive compensation expense. The Company expects continued revenue growth at CSI for the remainder of 2026 compared with 2025.
Healthcare also includes Graham Healthcare Group (GHG), which provides home health and hospice services in seven states. In March 2026, GHG acquired Covenant Home Health of Havertown, PA, a home health provider in Eastern Pennsylvania. Healthcare also includes Clarus (provides call management SaaS-based solution for physician groups and hospitals), Impact Medical (an allergy, asthma and immunology physician practice), Skin Clique (a concierge provider of aesthetics products and services) and Surpass Behavioral Health (provides therapy for autism patients). Revenue increased in other healthcare businesses by 12% and 11% in the second quarter and first six months of 2026 from growth in home health and hospice services and each of the other healthcare businesses. Operating results improved at home health and hospice in the second quarter and first six months of 2026, partly due to a reduction in pension expense. Overall, operating results declined at the other four healthcare businesses in the second quarter and first six months of 2026.
The Company also holds interests in four home health and hospice joint ventures managed by GHG, whose results are included in equity in earnings of affiliates in the Company’s Condensed Consolidated Statements of Operations. The Company recorded equity in earnings of $3.6 million and $3.4 million for the second quarters of 2026 and 2025, respectively, from these joint ventures. The Company recorded equity in earnings of $7.1 million and $6.6 million for the first six months of 2026 and 2025, respectively, from these joint ventures.
Manufacturing
A summary of manufacturing’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20262025% Change20262025% Change
Revenue$133,280 $96,218 39 $258,314 $194,223 33 
Operating Income
7,101 7,566 (6)15,101 13,046 16 
Manufacturing includes four businesses: Hoover, a supplier of pressure impregnated kiln-dried lumber and plywood products for fire retardant and preservative applications, and aluminum cladding products for the non-residential market; Dekko, a manufacturer of electrical workspace solutions, architectural lighting and electrical components and assemblies; Joyce, a manufacturer of screw jacks and other linear motion systems; and Forney, a global supplier of products and systems that control and monitor combustion processes in electric utility and industrial applications. On July 15, 2025, Hoover acquired Arconic Architectural Products, LLC, a wholly-owned subsidiary of Arconic Corporation (operating as Hoover Architectural Solutions), which manufactures aluminum cladding products and operates within the broader non-residential materials space from its facility in Eastman, GA. A significant portion of the purchase price was funded by the Company’s assumption of $107.5 million in net pension obligations.
Manufacturing revenues increased 39% and 33% in the second quarter and first six months of 2026, respectively, due to increased revenues at Hoover, Joyce and Forney, partially offset by lower revenues at Dekko. The revenue increase at Hoover is due largely to the Hoover Architectural Solutions business acquisition. Excluding the acquisition, overall volumes increased in the second quarter and first six months of 2026. Hoover results included
36


wood gains on inventory sales in both the second quarter and first six months of 2026 and 2025. Manufacturing operating results declined in the second quarter of 2026 due to an overall decline at Hoover from increased intangible asset amortization and transition costs related to the Arconic acquisition, along with declines at Forney and Dekko, partially offset by significant growth at Joyce. Manufacturing operating results increased in the first six months of 2026 due to significant growth at Joyce, and improved results at Dekko. The increase was partially offset by an overall decline at Hoover from increased intangible asset amortization and transition costs related to the Arconic acquisition, and a modest decline at Forney.
In the second quarter of 2026, the Company offered a VRIP to certain employees at Dekko; $2.0 million in related non-operating pension expense was recorded. In the first quarter of 2026, the Company offered a SIP to certain employees at Dekko and Joyce; $0.2 million in related non-operating pension expense was recorded. These programs were funded from the assets of the Company’s pension plan.
Automotive
A summary of automotive’s operating results is as follows:
Three Months EndedSix Months Ended
  June 30  June 30  
(in thousands)20262025% Change20262025% Change
Revenue$301,352 $285,572 $568,976 $566,563 
Operating Income8,065 9,293 (13)13,373 15,785 (15)
Automotive includes eight automotive dealerships in the Washington, DC metropolitan area and Richmond, VA: Ourisman Lexus of Rockville, Ourisman Honda of Tysons Corner, Ourisman Ford of Manassas, Toyota of Woodbridge, Ourisman Chrysler-Dodge-Jeep-Ram of Woodbridge, Ourisman Toyota of Richmond, and Ourisman Kia of Bethesda. In addition, on October 21, 2025, the Company acquired a Honda automotive dealership in Woodbridge, VA, including the real property for the dealership operations. Automotive also includes Roda, which provides valet automotive repair services in the Washington, DC metropolitan area. Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships, and his team of industry professionals operate and manage the dealerships; the Company holds a 90% stake.
The Company ceased operations of the Ourisman Jeep of Bethesda dealership, which was closed in early September 2025.
Revenues for the second quarter of 2026 increased 6% due partly to increased revenues from the Honda of Woodbridge dealership acquisition, offset by the closure of the Ourisman Jeep of Bethesda dealership in September 2025. Excluding these dealerships, revenues were down mostly from declines in used vehicle sales, partially offset by sales growth for new vehicles and services and parts. Operating results were down in the second quarter of 2026 due largely to lower gross profits on new and used vehicles, partially offset by earnings from the Honda of Woodbridge dealership acquisition, the closure of the Ourisman Jeep of Bethesda dealership, and higher overall gross profits on services and parts.
Revenues for the first six months of 2026 increased slightly due partly to increased revenues from the Honda of Woodbridge dealership acquisition, offset by the closure of the Ourisman Jeep of Bethesda dealership in September 2025. Excluding these dealerships, revenues were down mostly from declines in new and used vehicle sales, partially offset by sales growth for services and parts. Operating results were down in the first six months of 2026 due largely to lower gross profits on new and used vehicles, partially offset by earnings from the Honda of Woodbridge dealership acquisition, the closure of the Ourisman Jeep of Bethesda dealership, and higher overall gross profits on services and parts.
37


Other Businesses
A summary of revenue by category for other businesses:
Three Months EndedSix Months Ended
June 30%June 30%
20262025Change20262025Change
Operating Revenues
Specialty (1)
$45,747 $42,750 $84,825 $81,513 
Retail (2)
30,588 27,257 12 57,685 53,379 
Media (3)
16,504 18,963 (13)32,256 38,975 (17)
$92,839 $88,970 $174,766 $173,867 
____________
(1)
Includes Clyde’s Restaurant Group (CRG), Decile and Supporting Cast
(2)
Includes Framebridge, Saatchi Art and Society6
(3)
Includes Slate, Foreign Policy, Code3, World of Good Brands (WGB) (sold in 2025) and City Cast
Overall, revenue from other businesses increased 4% and 1% in the second quarter and first six months of 2026. Specialty revenue increased due to revenue growth at CRG and Supporting Cast. Retail revenue increased due to revenue growth at Framebridge and Saatchi Art, partially offset by lower revenue at Society6. Media revenue declined due to the sale of WGB and lower revenue at Slate and Code3, partially offset by revenue growth at Foreign Policy and City Cast.
Overall, operating losses at other businesses were down in the second quarter and first six months of 2026, due to a reduction of losses from the sale of WGB and improved results at Society6, Saatchi Art, Decile, Code3 and Supporting Cast, partially offset by declines at CRG, Framebridge, Slate, City Cast and Foreign Policy.
Clyde’s Restaurant Group
CRG owns and operates 14 restaurants and entertainment venues in the Washington, DC metropolitan area, including Old Ebbitt Grill and The Hamilton. Revenue was up in the second quarter and first six months of 2026. CRG reported an operating profit for the second quarter and first six months of 2026 and 2025, with operating results down for the first half of 2026 due to severe weather conditions and the temporary closure of two restaurants and related repair work that was completed early in the first quarter of 2026.
In the second quarter of 2026, operations commenced under a Clyde’s licensing agreement at Dulles International Airport. CRG plans to open a new restaurant in Reston, VA in the fourth quarter of 2026.
Framebridge
Framebridge is a custom framing service company, headquartered in the Washington, DC metropolitan area, with 48 retail locations, and four manufacturing facilities in Kentucky, Virginia and Nevada (opened in the third quarter of 2025). In the first six months of 2026, Framebridge opened four new retail stores. Framebridge plans to open additional stores and manufacturing facilities in the second half of 2026, and continues to actively explore other opportunities for further store and manufacturing expansion.
Revenues grew in the second quarter and first six months of 2026 due to an increase in retail revenue from same-store sales growth and operating additional retail stores compared to the same periods in 2025, and a modest increase in online revenues. Framebridge is an investment stage business and reported significant operating losses in the first six months of 2026 and 2025. Framebridge operating results include ongoing expansion investments from new retail store openings and manufacturing facilities.
In the first quarter of 2026, the Company offered a SIP to certain employees at Framebridge; $0.2 million in related non-operating pension expense was recorded. This program was funded from the assets of the Company’s pension plan.
Other
Other businesses also include Code3, a performance marketing agency focused on driving performance for brands though three core elements of digital success: media, creative and commerce; Slate and Foreign Policy, which publish online and print magazines and websites; Saatchi Art and Society6, which offer art and designs of various consumer products; and three investment stage businesses, Decile, City Cast and Supporting Cast. Foreign Policy, Saatchi Art, Supporting Cast and City Cast reported revenue growth in the first six months of 2026, while Society6, Slate, Code3 and Decile reported revenue declines. Losses from City Cast, Society6, Slate, Decile, Saatchi Art and Code3 in the first six months of 2026 adversely affected operating results, while Foreign Policy reported an operating profit.
38


In the second quarter of 2026, the Company offered a SIP to certain employees at Code3 and Slate; $0.3 million in related non-operating pension expense was recorded. In the first quarter of 2026, the Company offered SIPs to certain employees at Slate and Code3; $1.0 million in related non-operating pension expense was recorded. In the second quarter of 2025, the Company offered SIPs to certain employees at Code3, Saatchi Art, Society6, WGB and Decile; $5.2 million in related non-operating pension expense was recorded. In the first quarter of 2025, WGB offered a SIP; $0.6 million in related non-operating pension expense was recorded. These programs were funded from the assets of the Company’s pension plan.
Corporate Office
Corporate office includes the expenses of the Company’s corporate office and certain continuing obligations related to prior business dispositions. Corporate expenses were higher in the first half of 2026 due largely to increased legal and tax professional services costs.
Equity in Earnings (Losses) of Affiliates
At June 30, 2026, the Company held an approximate 25% interest in Intersection, a company that provides digital marketing and advertising services and products for cities, transit systems, airports, and other public and private spaces; and a 41.4% interest on a fully diluted basis in Realm. The Company also holds interests in several other affiliates, including a number of home health and hospice joint ventures managed by GHG and a joint venture managed by Kaplan. Overall, the Company recorded equity in losses of affiliates of $19.9 million for the second quarter of 2026, compared to earnings of $3.1 million for the second quarter of 2025. These amounts include $17.9 million and $0.4 million in net losses for the second quarter of 2026 and 2025, respectively, from affiliates whose operations are not managed by the Company. The 2026 amount also included a $5.8 million impairment loss on the Company’s investment in Realm.
The Company recorded equity in earnings of affiliates of $15.0 million for the first six months of 2026, compared to losses of $5.3 million for the first six months of 2025. These amounts include $13.1 million in net earnings and $12.3 million in net losses for the first six months of 2026 and 2025, respectively, from affiliates whose operations are not managed by the Company. The 2026 amount also included a $5.8 million impairment loss on the Company’s investment in Realm.
Net Interest Expense and Related Balances
On November 24, 2025, the Company issued $500 million of 5.625% unsecured eight-year fixed-rate notes due December 1, 2033 (the Notes). Interest is paid semi-annually on June 1 and December 1. Also on November 24, 2025, the Company used the net proceeds from the sale of the Notes, together with the borrowings under the revolving credit agreement, to (i) redeem the $400 million of 5.75% unsecured notes due June 1, 2026, (ii) refinance outstanding revolving loans under the existing revolving credit facility, and (iii) repay all amounts outstanding under the Company’s existing $150 million term loan. On October 21, 2025, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition of a Honda automotive dealership, including the real property for the dealership operations.
The Company incurred net interest expense of $15.3 million and $29.0 million for the second quarter and first six months of 2026, compared to $15.8 million and $95.6 million for the second quarter and first six months of 2025.
The Company recorded a reduction in interest expense of $0.2 million and $0.9 million in the second quarter and first six months of 2026, respectively, compared to interest expense of $1.2 million and $67.6 million in the second quarter and first six months of 2025, to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG. The significant adjustment recorded in the first quarter of 2025 is largely related to a substantial increase in the estimated fair value of CSI. On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.
Excluding these adjustments, the increase in net interest expense relates primarily to higher debt balances.
At June 30, 2026, the Company had $900.4 million in borrowings outstanding at an average interest rate of 5.7%, and cash, marketable equity securities and other investments of $1,297.4 million. At June 30, 2026, the Company had $231.2 million outstanding on its $400 million revolving credit facility.
Non-operating Pension and Postretirement Benefit Income, net
The Company recorded net non-operating pension and postretirement benefit income of $169.6 million and $200.7 million for the second quarter and first six months of 2026, compared to $28.6 million and $63.2 million for the second quarter and first six months of 2025.
39


In the second quarter of 2026, the Company recorded a pre-tax, noncash settlement gain of $137.0 million in connection with the purchase of an irrevocable group annuity contract from an insurance company.
Also in the second quarter of 2026, the Company recorded $3.8 million in expenses related to non-operating SIPs at Kaplan, the television broadcasting division, and other businesses and a VRIP at manufacturing. In the first quarter of 2026, the Company recorded $4.1 million in expenses related to non-operating SIPs at Kaplan, the television broadcasting division, manufacturing, other businesses and the Corporate office.
In the second quarter of 2025, the Company recorded $6.0 million in expenses related to non-operating SIPs at the education and television broadcasting divisions and other businesses. In the first quarter of 2025, the Company recorded $0.6 million in expenses related to non-operating SIPs at other businesses.
Gain (Loss) on Marketable Equity Securities, net
Overall, the Company recognized $101.9 million and $33.0 million in net gains on marketable equity securities in the second quarter and first six months of 2026, compared to $11.5 million in net losses and $32.3 million in net gains on marketable equity securities in the second quarter and first six months of 2025.
Other Non-Operating Expense
The Company recorded total other non-operating expense, net, of $2.5 million for the second quarter of 2026, compared to $16.5 million for the second quarter of 2025. The 2026 amounts included a $5.2 million loss on the sale of KLG, partially offset by $0.7 million in foreign currency gains and other items. The 2025 amounts included a $12.7 million impairment on a cost method investment and $4.5 million in foreign currency losses; partially offset by $0.4 million gain on sale of businesses and other items.
The Company recorded total other non-operating expense, net, of $3.0 million for the first six months of 2026, compared to $20.5 million for the first six months of 2025. The 2026 amounts included a $5.2 million loss on the sale of KLG and $0.6 million in foreign currency losses, partially offset by a $0.5 million gain on sale of a cost method investment and other items. The 2025 amounts included a $12.7 million impairment on a cost method investment and $8.9 million in foreign currency losses; partially offset by $0.4 million gain on sale of businesses and other items.
Provision for Income Taxes
The Company’s effective tax rate for the first six months of 2026 and 2025 was 12.6% and 29.8%, respectively.
The Company recognized a U.S. income tax benefit of $69.6 million during the six months ended June 30, 2026, in connection with the restructuring and sale of the KLG business. As a result of this significant U.S. income tax benefit, the Company accrued a non-U.S. global minimum corporate top-up income tax expense of $19.2 million in the second quarter of 2026. This accrual relates to non-U.S. jurisdictions that have not yet enacted legislation adopting recent guidance from the Organization for Economic Co-operation and Development (OECD), which would exempt U.S. parent multinational groups from Pillar Two top-up tax on their U.S. source income. The enactment of legislation in the U.K. and other jurisdictions would have a favorable impact on the Company’s income tax provision and could result in a complete reversal of the $19.2 million accrued amount without payment.
The Company’s effective tax rate for the first six months of 2025 was based on the estimated full year 2025 effective tax rate, which includes the adverse impact of the permanent difference related to the interest expense recorded to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG.
Earnings Per Share
The calculation of diluted earnings per share for the second quarter and first six months of 2026 was based on 4,309,444 and 4,342,014 weighted average shares outstanding, respectively, compared to 4,372,639 and 4,365,534 for the second quarter and first six months of 2025. At June 30, 2026, there were 4,251,268 shares outstanding. On September 12, 2024, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock; the Company has remaining authorization for 352,011 shares as of June 30, 2026.
40


Financial Condition: Liquidity and Capital Resources
The Company considers the following when assessing its liquidity and capital resources:
 As of
(In thousands)June 30, 2026December 31, 2025
Cash and cash equivalents$156,766 $266,988 
Restricted cash51,342 44,417 
Investments in marketable equity securities and other investments1,089,301 1,088,970 
Total debt900,373 880,756 
Cash generated by operations is the Company’s primary source of liquidity. The Company maintains investments in a portfolio of marketable equity securities, which is considered when assessing the Company’s sources of liquidity. An additional source of liquidity includes the undrawn portion of the Company’s $400 million revolving credit facility, amounting to $168.8 million at June 30, 2026.
During the first six months of 2026, the Company’s cash and cash equivalents decreased by $110.2 million, due to share repurchases; capital expenditures; business acquisitions and dispositions; dividend payments; and the redemption of noncontrolling interests. The decrease was partially offset by cash generated from operations, proceeds from the net sale of marketable equity securities and the repayment of a related party loan. In the first six months of 2026, the Company’s borrowings increased by $19.6 million, primarily due to increases in other debt and additional borrowings under the revolving credit facility, partially offset by repayments under the commercial notes at the automotive subsidiary.
As of June 30, 2026 and December 31, 2025, the Company had money market investments of $7.3 million and $5.3 million, that are included in cash and cash equivalents. At June 30, 2026, the Company held approximately $76 million in cash and cash equivalents in businesses domiciled outside the U.S., of which approximately $6 million is not available for immediate use in operations or for distribution. Additionally, Kaplan’s business operations outside the U.S. retain cash balances to support ongoing working capital requirements, capital expenditures, and regulatory requirements. As a result, the Company considers a significant portion of the cash and cash equivalents balance held outside the U.S. as not readily available for use in U.S. operations.
At June 30, 2026, the fair value of the Company’s investments in marketable equity securities was $1,083.1 million, which includes investments in the common stock of five publicly traded companies. During the first six months of 2026, the Company purchased $18.7 million of marketable equity securities and sold marketable equity securities that generated proceeds of $50.0 million. At June 30, 2026, the net unrealized gain related to the Company’s investments totaled $812.1 million.
The Company had working capital of $1,049.8 million and $1,042.5 million at June 30, 2026 and December 31, 2025, respectively. The Company maintains working capital levels consistent with its underlying business requirements and consistently generates cash from operations in excess of required interest or principal payments.
At June 30, 2026 and December 31, 2025, the Company had borrowings outstanding of $900.4 million and $880.8 million, respectively. The Company’s borrowings at June 30, 2026 were mostly from $500.0 million of 5.625% unsecured notes due December 1, 2033, $231.2 million in outstanding borrowings under the Company’s revolving credit facility, and real estate and capital term loans of $149.6 million at the automotive subsidiary. The Company’s borrowings at December 31, 2025 were mostly from $500.0 million of 5.625% unsecured notes due December 1, 2033, $222.5 million in outstanding borrowings under the Company’s revolving credit facility, and real estate and capital term loans of $155.9 million at the automotive subsidiary.
On November 24, 2025, the Company issued $500 million of 5.625% unsecured eight-year fixed-rate notes due December 1, 2033. Interest is paid semi-annually on June 1 and December 1. Also on November 24, 2025, the Company used the net proceeds from the sale of the notes, together with the borrowings under the revolving credit agreement, to (i) redeem the $400 million of 5.75% unsecured notes due June 1, 2026, (ii) refinance outstanding revolving loans under the existing revolving credit facility, and (iii) repay all amounts outstanding under the Company’s existing $150 million term loan.
In combination with the issuance of the Notes, the Company amended and restated the Second Amended and Restated Five Year Credit Agreement, dated as of May 3, 2022, to, among other things, (i) increase the Company’s borrowing capacity by replacing the existing revolving commitments with a new revolving credit facility in the aggregate principal amount of $400 million, (ii) extend the maturity of the facility to November 24, 2030, and (iii) increase the letter of credit sublimit to $40 million.
41


On October 21, 2025, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition of a Honda automotive dealership, including the real property for the dealership operations.
During the six months ended June 30, 2026 and 2025, the Company had average borrowings outstanding of approximately $895.5 million and $828.7 million, respectively, at average annual interest rates of approximately 5.7% and 6.0%, respectively. During the six months ended June 30, 2026 and 2025, the Company incurred net interest expense of $29.0 million and $95.6 million, respectively. Included in the net interest expense for the six months ended June 30, 2026 and 2025 is a $0.9 million reduction in interest expense and $67.6 million of interest expense, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest (see Notes 7 and 8).
On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest related to GHC One, including CSI, for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.
The settlement agreement resulted in a $66.2 million increase to the mandatorily redeemable noncontrolling interest obligation, which the Company recorded as interest expense in the first quarter of 2025. The remaining mandatorily redeemable noncontrolling interest obligation related to GHC One and GHC Two was $7.4 million at June 30, 2026.
On June 15, 2026, Standard & Poor’s affirmed the Company’s credit rating and maintained the outlook as Stable. On November 12, 2025, Moody’s affirmed the Company’s credit rating and maintained the outlook as Stable.
The Company’s current credit ratings are as follows:
Moody’sStandard & Poor’s
Long-termBa1BB
OutlookStableStable
The Company expects to fund its estimated capital needs primarily through existing cash balances and internally generated funds, and, as needed, from borrowings under its revolving credit facility. As of June 30, 2026, the Company had $231.2 million outstanding under the $400 million revolving credit facility. In management’s opinion, the Company will have sufficient financial resources to meet its business requirements in the next 12 months, including working capital requirements, capital expenditures, interest payments, potential acquisitions and strategic investments, dividends and stock repurchases.
In summary, the Company’s cash flows for each period were as follows:
 Six Months Ended 
 June 30
(In thousands)20262025
Net cash provided by operating activities$120,410 $140,810 
Net cash used in investing activities(48,840)(31,317)
Net cash used in financing activities(172,462)(188,512)
Effect of currency exchange rate change(2,405)10,514 
Net decrease in cash and cash equivalents and restricted cash$(103,297)$(68,505)
Operating Activities. Cash provided by operating activities is net income adjusted for certain non-cash items and changes in assets and liabilities. The Company’s net cash flow provided by operating activities were as follows:
 Six Months Ended 
 June 30
(In thousands)20262025
Net Income$313,127 $66,144 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation, amortization and goodwill and other asset impairments67,737 55,271 
Amortization of lease right-of-use asset29,343 28,729 
Net pension benefit, settlement gain and early retirement and special separation benefit expense(179,035)(40,985)
Other non-cash activities17,228 9,287 
Change in operating assets and liabilities(127,990)22,364 
Net Cash Provided by Operating Activities$120,410 $140,810 
42


Net cash provided by operating activities consists primarily of cash receipts from customers, less disbursements for costs, benefits, income taxes, interest and other expenses.
For the first six months of 2026 compared to the first six months of 2025, the decrease in net cash provided by operating activities is primarily driven by changes in operating assets and liabilities, offset by higher net income, net of non-cash adjustments. Changes in operating assets and liabilities were driven by higher purchases of inventory and a significant decrease in the interest expense related to the mandatorily redeemable noncontrolling interest, offset by an increase in customer collections.
Investing Activities. The Company’s net cash flow used in investing activities were as follows:
 Six Months Ended 
 June 30
(In thousands)20262025
Net proceeds from sales (purchases) of marketable equity securities$31,298 $(4,823)
Net (payments on) proceeds from disposition of businesses, property, plant and equipment and investments(40,050)7,348 
Purchases of property, plant and equipment(39,233)(32,285)
Investments in certain businesses, net of cash acquired(18,237)(2,523)
Proceeds from repayment of related party loan16,273 — 
Other1,109 966 
Net Cash Used in Investing Activities$(48,840)$(31,317)
Net proceeds from sales (purchases) of marketable equity securities. During the first six months of 2026, the Company sold marketable equity securities that generated proceeds of $50.0 million. There were no sales of marketable equity securities during the first six months of 2025. The Company purchased $18.7 million and $4.8 million of marketable equity securities during the first six months of 2026 and 2025, respectively.
Disposition of Businesses. In May 2026, Kaplan completed the sale of the KLG business, which is included in Kaplan international. KLG comprised Kaplan International Languages, Alpadia Language Schools, Azurlingua and English as a second language (ESL) Education. In April 2025, Kaplan completed the sale of a small business, BridgeU Limited, which was included in Kaplan International. In the first half of 2025, WGB completed the sale of various websites and related businesses that made up the WGB operations. All remaining WGB operations were substantially shut down by the end of the third quarter of 2025.
Capital Expenditures. The amounts reflected in the Company’s Condensed Consolidated Statements of Cash Flows are based on cash payments made during the relevant periods, whereas the Company’s capital expenditures for the first six months of 2026 and 2025 disclosed in Note 16 to the Condensed Consolidated Financial Statements include assets acquired during the period. The Company estimates that its capital expenditures will be in the range of $90 million to $100 million in 2026.
Acquisitions. In March 2026, the Company acquired one small business which is included in other healthcare businesses. In June 2025, Kaplan acquired one small business which is included in its supplemental education division.
Proceeds from repayment of related party loan. In the second quarter of 2026, the Company received $16.3 million from Purdue Global related to the advance of $20.0 million during the initial KU transaction.
Financing Activities. The Company’s net cash flow used in financing activities were as follows:
 Six Months Ended 
 June 30
(In thousands)20262025
Common shares repurchased$(121,985)$(3,468)
Purchase of noncontrolling interests(17,340)— 
Dividends paid(16,311)(15,660)
Repayments of borrowings(15,194)(13,172)
Net borrowing under revolving credit facility13,092 75,000 
Net repayments of vehicle floor plan payable(1,863)(32,776)
Distributions paid to noncontrolling interests(4,355)(190,319)
Other(8,506)(8,117)
Net Cash Used in Financing Activities$(172,462)$(188,512)
43


Common Stock Repurchases. During the first six months of 2026, the Company purchased a total of 110,471 shares of its Class B common stock at a cost of approximately $123.2 million, including commissions and accrued excise tax of $1.2 million. On September 12, 2024, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock. The Company did not announce a ceiling price or time limit for the purchases. At June 30, 2026, the Company had remaining authorization from the Board of Directors to purchase up to 352,011 shares of Class B common stock.
Transactions with minority shareholders. In March 2026, the Company acquired some of the minority-owned shares of CSI for a total amount of $41.0 million. The Company paid cash of $16.4 million and entered into promissory notes with the minority owners for the remaining $24.6 million. In January 2026, pursuant to the exercise of a put right, the Company purchased some of the minority-owned interest of Clarus for $1.0 million.
On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest related to GHC One, including CSI, for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.
Dividends. The quarterly dividend rate per share was $1.88 and $1.80 for the first six months of 2026 and 2025, respectively. The Company expects to pay a dividend of $7.52 per share in 2026.
Borrowings and Vehicle Floor Plan Payable. In the first six months of 2026, the Company repaid amounts borrowed under the commercial notes at the automotive subsidiary and other debt and made additional borrowings on the $400 million revolving credit facility. In the first six months of 2025, the Company made additional borrowings on the $300 million revolving credit facility and repaid amounts borrowed under the term loan and commercial notes at the automotive subsidiary. In the first six months of 2026 and 2025, the Company used vehicle floor plan financing to fund the purchase of new, used and service loaner vehicles at its automotive subsidiary. The repayments of vehicle floor plan payable fluctuates with changes in the amount of vehicle inventory held by the automotive dealerships.
There were no other significant changes to the Company’s contractual obligations or other commercial commitments from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Forward-Looking Statements
All public statements made by the Company and its representatives that are not statements of historical fact, including certain statements in this report, in the Company’s Annual Report on Form 10-K and in the Company’s 2025 Annual Report to Stockholders, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations, forecasts, and assumptions by the Company’s management and involve a number of risks, uncertainties, and other factors that could cause actual results to differ from those stated, including, without limitation, comments about expectations related to acquisitions or dispositions or related business activities, the Company’s business strategies and objectives, the prospects for growth in the Company’s various business operations, the Company’s future financial performance, and the risks and uncertainties described in Item 1A of the Company’s Annual Report on Form 10-K. Accordingly, undue reliance should not be placed on any forward-looking statement made by or on behalf of the Company. The Company assumes no obligation to update any forward-looking statement after the date on which such statement is made, even if new information subsequently becomes available.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
The Company is exposed to market risk in the normal course of its business due primarily to its ownership of marketable equity securities, which are subject to equity price risk; to its borrowing and cash-management activities, which are subject to interest rate risk; and to its foreign business operations, which are subject to foreign exchange rate risk. The Company’s market risk disclosures set forth in its 2025 Annual Report filed on Form 10-K have not otherwise changed significantly.
Item 4. Controls and Procedures.
(a) Evaluation of Disclosure Controls and Procedures
An evaluation was performed by the Company’s management, with the participation of the Company’s Chief Executive Officer (principal executive officer) and the Company’s Chief Financial Officer (principal financial officer), of the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), as of June 30, 2026. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures, as designed and implemented, are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within
44


the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.
(b) Changes in Internal Control Over Financial Reporting
There has been no change in the Company’s internal control over financial reporting during the quarter ended June 30, 2026 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
45


PART II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
During the quarter ended June 30, 2026, the Company purchased shares of its Class B Common Stock as set forth in the following table:
PeriodTotal Number of Shares Purchased
Average Price Paid per Share(1)
Total Number of Shares Purchased as Part of Publicly Announced Plan(2)
Maximum Number of Shares that May Yet Be Purchased Under the Plan(2)
April 1 - 3027,271 $1,125.38 27,271 403,021 
May 1 - 3125,980 1,127.73 25,980 377,041 
June 1 - 3025,030 1,147.84 25,030 352,011 
78,281 $1,133.34 78,281 
(1) Average price paid per share includes costs associated with repurchases, including commissions and excise taxes.
(2) On September 12, 2024, the Company’s Board of Directors authorized the Company to purchase, on the open market or otherwise, up to 500,000 shares of its Class B Common Stock. This authorization includes shares that remained under the previous authorization. There is no expiration date for this authorization. Share purchases made during the quarter ended June 30, 2026 were open market transactions or transactions to settle employee tax withholding obligations related to the vesting of restricted stock awards.
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the quarter ended June 30, 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.
46


Item 6. Exhibits.
Exhibit Number 
Description 
3.1
Restated Certificate of Incorporation of the Company dated November 13, 2003 (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2003).
3.2
Certificate of Amendment, effective November 29, 2013, to the Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s current Report on Form 8-K dated November 29, 2013).
3.3
By-Laws of the Company as amended and restated through September 12, 2024 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K dated September 12, 2024).
4.1
Senior Notes Indenture dated as of November 24, 2025, between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K dated November 24, 2025).
31.1
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
31.2
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
32
Section 1350 Certification of the Chief Executive Officer and the Chief Financial Officer. *
101.INS
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101
*     Furnished herewith.
47


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  GRAHAM HOLDINGS COMPANY
  (Registrant)
   
Date: July 30, 2026 /s/ Timothy J. O’Shaughnessy
  
Timothy J. O’Shaughnessy,
President & Chief Executive Officer
(Principal Executive Officer)
   
Date: July 30, 2026 /s/ Wallace R. Cooney
  Wallace R. Cooney,
Chief Financial Officer
(Principal Financial Officer)
48